Karin Ekström Smedby

About me
Publications
Grants
CV
Public outreach and news

About me

Karin Ekström Smedby is a professor of haematology-oncology, focusing on clinical epidemiology.
The main research focus is risk, survival and survivorship in malignant lymphomas.

PhD, Karolinska Institutet, 2005
MD, Uppsala University, 1994

Teaching

I have supervised 9 doctoral students as main supervisor, and 5 as co-supervisor, to thesis defense.
I was course leader of two week-long courses in epidemiology (Introduction to Epidemiology, and, Next steps in Epidemiology) at the National Research School in Oncology (NatiOn).
I was study director of the Research School in Epidemiology for Clinicians at Karolinska Institutet and Region Stockholm 2007-2009

Selected publications

Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(31):3463-3472
Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study
Ovlisen AK; Jakobsen LH; Eloranta S; Kragholm KH; Hutchings M; Frederiksen H; Kamper P; Dahl-Sorensen RB; Stoltenberg D; Weibull CE; Entrop JP; Glimelius I; Smedby KE; Torp-Pedersen C; Severinsen MT; El-Galaly TC
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(5):1048-1060
Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study
Ekberg S; Harrysson S; Jernberg T; Szummer K; Andersson P-O; Jerkeman M; Smedby KE; Eloranta S
Letter: BLOOD CANCER JOURNAL. 2021;11(5):100
Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study
Wasterlid T; Hasselblom S; Joelsson J; Weibull CE; Rassidakis G; Sander B; Smedby KE
Editorial comment: LANCET HAEMATOLOGY. 2021;8(4):e242-e243
Late toxicities in non-Hodgkin lymphoma: extended follow-up matters.
Thanarajasingam G; Smedby KE; LaCasce A
Article: BLOOD ADVANCES. 2021;5(6):1638-1647
Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival
Glimelius I; Smedby KE; Albertsson-Lindblad A; Crowther MJ; Eloranta S; Jerkeman M; Weibull CE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(3):551-559
Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study
Wasterlid T; Oren Gradel K; Eloranta S; Glimelius I; El-Galaly TC; Frederiksen H; Smedby KE
Article: BLOOD CANCER JOURNAL. 2021;11(1):9
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
Harrysson S; Eloranta S; Ekberg S; Enblad G; Jerkeman M; Wahlin BE; Andersson P-O; Smedby KE
Review: JOURNAL OF INTERNAL MEDICINE. 2021;289(1):12-28
Cancer survival statistics for patients and healthcare professionals - a tutorial of real-world data analysis
Eloranta S; Smedby KE; Dickman PW; Andersson TM
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(6):652-661
Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients
Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):703-713
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study
Biccler JL; Glimelius I; Eloranta S; Smeland KB; Brown PDN; Jakobsen LH; Frederiksen H; Jerkeman M; Fossa A; Andersson TML; Holte H; Bogsted M; El-Galaly TC; Smedby KE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(33):JCO1800262-3323
Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up
Lockmer S; Ostenstad B; Hagberg H; Holte H; Johansson A-S; Wahlin BE; Wader KF; Steen CB; Meyer P; Maisenholder M; Smedby KE; Brown P; Kimby E

Articles

Article: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2024;46:100785
Stable use of radiotherapy in lymphoma patients over time - A comprehensive national overview of radiotherapy use in Sweden with focus on older patients
Glimelius I; Ekberg S; Smedby KE; Wasterlid T
Article: ACTA ONCOLOGICA. 2024;63:164-168
Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival - a Swedish Lymphoma Register Study
Ekberg S; Molin D; Pahnke S; Bergstroem F; Branvall E; Smedby KE; Waesterlid T
Article: LEUKEMIA & LYMPHOMA. 2024;65(4):534-537
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Harrysson S; Eloranta S; Ekberg S; Enblad G; Andersson P-O; Sonnevi K; Ljungqvist M; Sander B; Jerkeman M; Smedby KE
Article: LEUKEMIA. 2024;38(2):610-620
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
Ren W; Wan H; Abd Own S; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini R-M; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarstrom Q
Article: JOURNAL OF CANCER SURVIVORSHIP. 2024;:1-11
Long-term prescribed drug use in stage I-III rectal cancer patients in Sweden, with a focus on bowel-regulating drugs after surgical and oncological treatment
Boman SE; Fuentes S; Nordenvall C; Martling A; Chen L; Glimelius I; Neovius M; Smedby KE; Eloranta S
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2024;33(2):206-214
Potential for Cure by Stage across the Cancer Spectrum in the United States
Hubbell E; Clarke CA; Smedby KE; Adami H-O; Chang ET
Article: FRONTIERS IN ENDOCRINOLOGY. 2024;15:1360139
Long-term risk of neoplastic events after childhood growth hormone treatment: a population-based cohort study in Sweden
Tidblad A; Bottai M; Smedby KE; Albertsson-Wikland K; Saevendahl L
Article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(35):5376-5387
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma
Lewis KL; Jakobsen LH; Villa D; Smedby KE; Savage KJ; Eyre TA; Cwynarski K; Bishton MJ; Fox CP; Hawkes EA; Maurer MJ; El-Galaly TC; Cheah CY
Article: ACTA ONCOLOGICA. 2023;62(12):1599-1606
Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study
Rodriguez-Wallberg KA; Ahlgren J; Smedby KE; Gorman JR; Hellman K; Henriksson R; Stahl O; Wettergren L; Lampic C
Article: EUROPEAN JOURNAL OF CANCER. 2023;195:113403
Secondary malignancies among mantle cell lymphoma patients
Abalo KD; Smedby KE; Ekberg S; Eloranta S; Pahnke S; Albertsson-Lindblad A; Jerkeman M; Glimelius I
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(12):3132-3142
Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study
Olen O; Smedby KE; Erichsen R; Pedersen L; Halfvarson J; Hallqvist-Everhov A; Askling J; Ekbom A; Sachs MC; Sorensen HT; Ludvigsson JF
Article: LANCET HAEMATOLOGY. 2023;10(10):e838-e848
Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population- based, retrospective cohort study
Trab T; Baech J; Jakobsen LH; Husby S; Severinsen MT; Eloranta S; Gorlov JS; Jorgensen JM; Gudbrandsdottir S; Larsen TS; Brown P; Gronbaek K; Smedby KE; El-Galaly TC
Article: INTERNATIONAL JOURNAL OF CANCER. 2023;153(4):723-731
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study
Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Ovlisen AK; Molin D; Glimelius I; Marklund A; Holte H; Fossa A; Smeland KB; El-Galaly TC; Eloranta S
Article: HEMASPHERE. 2023;7(8):e928
Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete Project
Jerkeman M; Ekberg S; Glimelius I; Albertsson-Lindblad A; Entrop JP; Ellin F; Sonnevi K; Lewerin C; Brandefors L; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2023;202(4):785-795
Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study
Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Ovlisen AK; Glimelius I; Marklund A; Larsen TS; Holte H; Fossa A; Smeland KB; El-Galaly TC; Eloranta S
Article: BRITISH JOURNAL OF CANCER. 2023;128(12):2261-2269
Risk and mortality of testicular cancer in patients with neurodevelopmental or other psychiatric disorders
Jansson AK; Soderling J; Reutfors J; Thor A; Skold C; Cohn-Cedermark G; Stahl O; Smedby KEE; Pettersson A; Glimelius I
Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:474-475
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
Visco C; Malinverni C; Florea E; Glimelius I; Mirandola M; Ekström-Smedby K; Tisi MC; Giné E; Albertsson-Lindblad A; Niebla AM; Di Rocco A; Moita F; Sciarra R; Bašić-Kinda S; Hess G; Ohler A; Eskelund C; Re A; Ferrarini I; Kolstad A; Räty R; Quaglia FM; Bernardelli A; Eyre TA; Scapinello G; Stefani PM; Morello L; Nassi L; Hohaus S; Ragaini S; Zilioli VR; Bruna R; Cocito F; Arcari A; Jerkeman M
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2023;32(5):687-696
Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies
Argirion I; Pfeiffer RM; Proietti C; Coghill AE; Yu KJ; Middeldorp JM; Sarathkumara YD; Hsu W-L; Chien Y-C; Lou P-J; Wang C-P; Rothman N; Lan Q; Chen C-J; Mbulaiteye SM; Jarrett RF; Glimelius I; Smedby KE; Hjalgrim H; Hildesheim A; Doolan DL; Liu Z
Article: ACTA ONCOLOGICA. 2023;62(4):342-349
CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research
Weibull CEE; Boman SE; Glimelius B; Syk I; Matthiessen P; Smedby KEE; Nordenvall C; Martling A
Article: CANCER MEDICINE. 2023;12(8):9893-9901
Do young adults with cancer receive information about treatment- related impact on sex life? Results from a population-based study
Bergstrom C; Lampic C; Roy R; Hedman C; Ahlgren J; Stahl O; Smedby KE; Hellman K; Henriksson R; Eriksson LE; Wettergren L
Article: BLOOD ADVANCES. 2023;7(5):866-874
Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
Ekberg S; Smedby KE; Albertsson-Lindblad A; Jerkeman M; Weibull CE; Glimelius I
Article: HEMASPHERE. 2023;7(3):e838
Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden
Weibull CE; Wasterlid T; Wahlin BE; Andersson P-O; Ekberg S; Lockmer S; Enblad G; Crowther MJ; Kimby E; Smedby KE
Article: LEUKEMIA. 2023;37(2):339-347
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Mansouri L; Thorvaldsdottir B; Sutton L-A; Karakatsoulis G; Meggendorfer M; Parker H; Nadeu F; Brieghel C; Laidou S; Moia R; Rossi D; Catherwood M; Kotaskova J; Delgado J; Rodriguez-Vicente AE; Benito R; Rigolin GM; Bonfiglio S; Scarfo L; Mattsson M; Davis Z; Gogia A; Rani L; Baliakas P; Foroughi-Asl H; Jylha C; Skaftason A; Rapado I; Miras F; Martinez-Lopez J; de la Serna J; Rivas JMH; Thornton P; Larrayoz MJ; Calasanz MJ; Fesus V; Matrai Z; Bodor C; Smedby KE; Espinet B; Puiggros A; Gupta R; Bullinger L; Bosch F; Tazon-Vega B; Baran-Marszak F; Oscier D; N'Guyen-Khac F; Zenz T; Terol MJ; Cuneo A; Hernandez-Sanchez M; Pospisilova S; Mills K; Gaidano G; Niemann CU; Campo E; Strefford JC; Ghia P; Stamatopoulos K; Rosenquist R
Article: BRITISH JOURNAL OF DERMATOLOGY. 2023;188(1):32-40
Association of metformin use and survival in patients with cutaneous melanoma and diabetes
Krakowski I; Habel H; Nielsen K; Ingvar C; Andersson TML; Girnita A; Smedby KE; Eriksson H
Article: CANCER MEDICINE. 2023;12(1):315-324
Low-dose aspirin use and colorectal cancer survival in 32,195 patients-A national cohort study
Shahrivar M; Weibull CE; Ekstrom Smedby K; Glimelius B; Syk I; Matthiessen P; Nordenvall C; Martling A
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2023;98(1):23-30
Sex differences in lymphoma incidence and mortality by subtype: A population-based study
Radkiewicz C; Bruchfeld JB; Weibull CE; Jeppesen ML; Frederiksen H; Lambe M; Jakobsen L; El-Galaly TC; Smedby KE; Wasterlid T
Article: FRONTIERS IN ONCOLOGY. 2023;13:1176698
Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study
Haider Z; Wasterlid T; Spangberg LD; Rabbani L; Jylha C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hagglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
Article: LEUKEMIA. 2022;36(12):2835-2844
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
Berndt SI; Vijai J; Benavente Y; Camp NJ; Nieters A; Wang Z; Smedby KE; Kleinstern G; Hjalgrim H; Besson C; Skibola CF; Morton LM; Brooks-Wilson AR; Teras LR; Breeze C; Arias J; Adami H-O; Albanes D; Anderson KC; Ansell SM; Bassig B; Becker N; Bhatti P; Birmann BM; Boffetta P; Bracci PM; Brennan P; Brown EE; Burdett L; Cannon-Albright LA; Chang ET; Chiu BCH; Chung CC; Clavel J; Cocco P; Colditz G; Conde L; Conti DV; Cox DG; Curtin K; Casabonne D; De Vivo I; Diver WR; Dogan A; Edlund CK; Foretova L; Fraumeni JFJ; Gabbas A; Ghesquieres H; Giles GG; Glaser S; Glenn M; Glimelius B; Gu J; Habermann TM; Haiman CA; Haioun C; Hofmann JN; Holford TR; Holly EA; Hutchinson A; Izhar A; Jackson RD; Jarrett RF; Kaaks R; Kane E; Kolonel LN; Kong Y; Kraft P; Kricker A; Lake A; Lan Q; Lawrence C; Li D; Liebow M; Link BK; Magnani C; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Monnereau A; Montalvan R; North KE; Novak AJ; Onel K; Purdue MP; Rand KA; Riboli E; Riby J; Roman E; Salles G; Sborov DW; Severson RK; Shanafelt TD; Smith MT; Smith A; Song KW; Song L; Southey MC; Spinelli JJ; Staines A; Stephens D; Sutherland HJ; Tkachuk K; Thompson CA; Tilly H; Tinker LF; Travis RC; Turner J; Vachon CM; Vajdic CM; Van den Berg A; Van den Berg DJ; Vermeulen RCH; Vineis P; Wang SS; Weiderpass E; Weiner GJ; Weinstein S; Doo NW; Ye Y; Yeager M; Yu K; Zeleniuch-Jacquotte A; Zhang Y; Zheng T; Ziv E; Sampson J; Chatterjee N; Offit K; Cozen W; Wu X; Cerhan JR; Chanock SJ; Slager SL; Rothman N
Article: RMD OPEN. 2022;8(2):e002776
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study
Cordtz RL; Askling J; Delcoigne B; Smedby KE; Baecklund E; Ballegaard C; Isomaki P; Aaltonen K; Gudbjornsson B; Love TJ; Provan SA; Michelsen B; Sexton J; Dreyer L; Hellgren K
Article: BRITISH JOURNAL OF CANCER. 2022;127(9):1642-1649
Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission
Ekberg S; Crowther M; Harrysson S; Jerkeman M; Smedby KE; Eloranta S
Article: ACTA ONCOLOGICA. 2022;61(10):1165-1172
Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis - a population-based study
Wettergren L; Eriksson LE; Bergstrom C; Hedman C; Ahlgren J; Smedby KE; Hellman K; Henriksson R; Lampic C
Article: BLOOD ADVANCES. 2022;6(15):4427-4435
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
Baech J; Severinsen MT; Ovlisen AK; Frederiksen H; Vestergaard P; Torp-Pedersen C; Jorgensen J; Clausen MR; Poulsen CB; Brown P; Gang AO; Pedersen RS; Smedby KE; Eloranta S; Jakobsen LH; El-Galaly TC
Article: ACTA ONCOLOGICA. 2022;61(8):922-930
Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study
Udumyan R; Botteri E; Jerlstrom T; Montgomery S; Smedby KE; Fall K
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(2):267-277
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
Harrysson S; Eloranta S; Ekberg S; Enblad G; El-Galaly TC; Sander B; Sonnevi K; Andersson P-O; Jerkeman M; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;197(5):580-589
Checkpoint CD47 expression in classical Hodgkin lymphoma
Gholiha AR; Hollander P; Lof L; Glimelius I; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Hashemi J; Amini R-M; Enblad G
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2022;31(5):1103-1110
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; Casabonne D; Cerhan JR; Cozen W; Alarcón G; Martínez-Maza O; Brown EE; Bracci PM; Turner J; Hjalgrim H; Bhatti P; Zhang Y; Birmann BM; Flowers CR; Paltiel O; Holly EA; Kane E; Weisenburger DD; Maynadié M; Cocco P; Foretova L; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zheng T; Skibola CF; Clavel J; Monnereau A; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;108(5):369-378
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?
Brieghel C; Galle V; Agius R; Da Cunha-Bang C; Andersen MA; Vlummens P; Mattsson M; Rosenquist R; Smedby KE; Herling CD; Bahlo J; Hallek M; Lundgren JD; Offner F; Niemann CU
Article: BLOOD ADVANCES. 2022;6(8):2657-2666
Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study
Joelsson J; Wasterlid T; Rosenquist R; Jakobsen LH; El-Galaly TC; Smedby KE; Eloranta S
Article: JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. 2022;20(6):683-689.e2
Adjuvant Hormone Therapy-Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer
Zeng E; He W; Smedby KE; Czene K
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2022;31(3):528-535
Use of Antibiotics and Risk of Psychiatric Disorders in Newly Diagnosed Cancer Patients: A Population-Based Cohort Study in Sweden
Hu K; Smedby KE; Sjolander A; Montgomery S; Valdimarsdottir U; Engstrand L; Fang F; Fall K
Article: BMC CANCER. 2022;22(1):75
NSAID use and unnatural deaths after cancer diagnosis: a nationwide cohort study in Sweden
Shen Q; Sjolander A; Sloan EK; Walker AK; Fall K; Valdimarsdottir U; Sparen P; Smedby KE; Fang F
Article: FRONTIERS IN ONCOLOGY. 2022;12:984021
Data-driven support to decision-making in molecular tumour boards for lymphoma: A design science approach
Ruiz NR; Abd Own S; Smedby KE; Eloranta S; Koch S; Wasterlid T; Krstic A; Boman M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;195(4):552-560
Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era
Branvall E; Ekberg S; Eloranta S; Wasterlid T; Birmann BM; Smedby KE
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2021;50(4):1325-1334
Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer.
Besson C; Moore A; Wu W; Vajdic CM; de Sanjose S; Camp NJ; Smedby KE; Shanafelt TD; Morton LM; Brewer JD; Zablotska L; Engels EA; Cerhan JR; Slager SL; Han J; Berndt SI; InterLymph Consortium. Full authors list is given
Article: ACTA ONCOLOGICA. 2021;60(8):976-983
Fertility-related information received by young women and men with cancer - a population-based survey
Wide A; Wettergren L; Ahlgren J; Smedby KE; Hellman K; Henriksson R; Rodriguez-Wallberg K; Stahl O; Lampic C
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;194(3):568-579
Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden
Sima A; Hollander P; Baecklund E; Smedby KE; Enblad G; Amini R-M
Article: BLOOD ADVANCES. 2021;5(6):1671-1681
Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma
Gholiha AR; Hollander P; Glimelius I; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Hashemi J; Amini R-M; Enblad G
Article: CELLS. 2021;10(2):394
Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study.
Seyed Khoei N; Carreras-Torres R; Murphy N; Gunter MJ; Brennan P; Smith-Byrne K; Mariosa D; Mckay J; O'Mara TA; Jarrett R; Hjalgrim H; Smedby KE; Cozen W; Onel K; Diepstra A; Wagner K-H; Freisling H
Article: LEUKEMIA. 2021;35(2):476-484
Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients
Landtblom AR; Andersson TM-L; Dickman PW; Smedby KE; Eloranta S; Batyrbekova N; Samuelsson J; Bjorkholm M; Hultcrantz M
Article: RHEUMATOLOGY. 2021;60(2):809-819
Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype
Hellgren K; Di Giuseppe D; Smedby KE; Sundstrom C; Askling J; Baecklund E
Article: JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS. 2021;5:200-217
Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes.
Moore A; Machiela MJ; Machado M; Wang SS; Kane E; Slager SL; Zhou W; Carrington M; Lan Q; Milne RL; Birmann BM; Adami H-O; Albanes D; Arslan AA; Becker N; Benavente Y; Bisanzi S; Boffetta P; Bracci PM; Brennan P; Brooks-Wilson AR; Canzian F; Caporaso N; Clavel J; Cocco P; Conde L; Cox DG; Cozen W; Curtin K; De Vivo I; de Sanjose S; Foretova L; Gapstur SM; Ghesquières H; Giles GG; Glenn M; Glimelius B; Gao C; Habermann TM; Hjalgrim H; Jackson RD; Liebow M; Link BK; Maynadie M; McKay J; Melbye M; Miligi L; Molina TJ; Monnereau A; Nieters A; North KE; Offit K; Patel AV; Piro S; Ravichandran V; Riboli E; Salles G; Severson RK; Skibola CF; Smedby KE; Southey MC; Spinelli JJ; Staines A; Stewart C; Teras LR; Tinker LF; Travis RC; Vajdic CM; Vermeulen RCH; Vijai J; Weiderpass E; Weinstein S; Doo NW; Zhang Y; Zheng T; Chanock SJ; Rothman N; Cerhan JR; Dean M; Camp NJ; Yeager M; Berndt SI
Article: CLINICAL EPIDEMIOLOGY. 2021;13:21-41
Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
Ludvigsson JF; Appelros P; Askling J; Byberg L; Carrero J-J; Ekstrom AM; Ekstrom M; Smedby KE; Hagstrom H; James S; Jarvholm B; Michaelsson K; Pedersen NL; Sundelin H; Sundquist K; Sundstrom J
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(1):105-115
Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting
Krakowski I; Bottai M; Habel H; Masucci G; Girnita A; Smedby KE; Eriksson H
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(1):75-81
Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study
Sonnevi K; Wasterlid T; Melen CM; Harrysson S; Smedby KE; Wahlin BE
Article: TRANSPLANT INTERNATIONAL. 2020;33(12):1700-1710
Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study
Benoni H; Eloranta S; Dahle DO; Svensson MHS; Nordin A; Carstens J; Mjoen G; Helantera I; Hellstrom V; Enblad G; Pukkala E; Sorensen SS; Lempinen M; Smedby KE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(6):779-785
Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia
Baecklund F; Ekberg S; Rosenquist R; Askling J; Eloranta S; Smedby KE
Article: BREAST CANCER RESEARCH AND TREATMENT. 2020;183(3):669-675
Sarcoma of the breast: breast cancer history as etiologic and prognostic factor-A population-based case-control study
Karlsson F; Granath F; Smedby KE; Zedenius J; Branstrom R; Nilsson I-L
Article: BMC MEDICINE. 2020;18(1):238
Aspirin and other non-steroidal anti-inflammatory drugs and depression, anxiety, and stress-related disorders following a cancer diagnosis: a nationwide register-based cohort study
Hu K; Sjolander A; Lu D; Walker AK; Sloan EK; Fall K; Valdimarsdottir U; Hall P; Smedby KE; Fang F
Article: CANCER RESEARCH. 2020;80(16):3436-3442
Psychiatric Disorders Are Associated with Increased Risk of Sepsis Following a Cancer Diagnosis
Liu Q; Song H; Andersson TM-L; Magnusson PKE; Zhu J; Smedby KE; Fang F
Article: BJS OPEN. 2020;4(4):645-658
Increasing incidence of colorectal cancer among the younger population in Sweden
Petersson J; Bock D; Martling A; Smedby KE; Angenete E; Saraste D
Article: ACTA ONCOLOGICA. 2020;59(8):949-958
Birthweight and all-cause mortality after childhood and adolescent leukemia: a cohort of children with leukemia from Denmark, Norway, Sweden, and Washington State
Ording AG; Christensen LB; Bjorge T; Doody DR; Ekbom A; Glimelius I; Grotmol T; Larfors G; Mueller BA; Smedby KE; Tretli S; Troisi R; Sorensen HT
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;147(3):608-618
Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma
Liu Z; Jarrett RF; Hjalgrim H; Proietti C; Chang ET; Smedby KE; Yu KJ; Lake A; Troy S; McAulay KA; Pfeiffer RM; Adami H-O; Glimelius B; Melbye M; Hildesheim A; Doolan DL; Coghill AE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):740-748
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
Wasterlid T; Harrysson S; Andersson TM-L; Ekberg S; Enblad G; Andersson P-O; Jerkeman M; Eloranta S; Smedby KE
Article: BIOMEDICINES. 2020;8(6):E170-170
ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
Ghaderi A; Daneshmanesh AH; Moshfegh A; Kokhaei P; Vagberg J; Schultz J; Olin T; Harrysson S; Smedby KE; Drakos E; Rassidakis GZ; Osterborg A; Mellstedt H; Hojjat-Farsangi M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(6):1083-1092
Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study
Ekberg S; Smedby K; Glimelius I; Nilsson-Ehle H; Goldkuhl C; Lewerin C; Jerkeman M; Eloranta S
Article: JOURNAL OF INTERNAL MEDICINE. 2020;287(6):723-733
Family history of colorectal cancer and survival: a Swedish population-based study
Pesola F; Eloranta S; Martling A; Saraste D; Smedby KE
Article: BLOOD. 2020;135(21):1859-1869
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
Condoluci A; di Bergamo LT; Langerbeins P; Hoechstetter MA; Herling CD; De Paoli L; Delgado J; Rabe KG; Gentile M; Doubek M; Mauro FR; Chiodin G; Mattsson M; Bahlo J; Cutrona G; Kotaskova J; Deambrogi C; Smedby KE; Spina V; Bruscaggin A; Wu W; Moia R; Bianchi E; Gerber B; Zucca E; Gillessen S; Ghielmini M; Cavalli F; Stussi G; Hess MA; Baumann TS; Neri A; Ferrarini M; Rosenquist R; Forconi F; Foa R; Pospisilova S; Morabito F; Stilgenbauer S; Doehner H; Parikh SA; Wierda WG; Montserrat E; Gaidano G; Hallek M; Rossi D
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(5):597-605
Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patients
Udumyan R; Montgomery S; Duberg A-S; Fang F; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2020;49(3):225-232
Population-based study of patients with primary Sjogren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences
Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Ronnblom L; Sundstrom C; Baecklund E
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2020;29(5):1074-1078
Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study.
Kleinstern G; Camp NJ; Berndt SI; Birmann BM; Nieters A; Bracci PM; McKay JD; Ghesquières H; Lan Q; Hjalgrim H; Benavente Y; Monnereau A; Wang SS; Zhang Y; Purdue MP; Zeleniuch-Jacquotte A; Giles GG; Vermeulen R; Cocco P; Albanes D; Teras LR; Brooks-Wilson AR; Vajdic CM; Kane E; Caporaso NE; Smedby KE; Salles G; Vijai J; Chanock SJ; Skibola CF; Rothman N; Slager SL; Cerhan JR
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(4):661-671
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients
Jakobsen LH; Ellin F; Smeland KB; Wasterlid T; Christensen JH; Jorgensen JM; Josefsson PL; Ovlisen AK; Holte H; Blaker YN; Grauslund JH; Bjorn J; Molin D; Lagerlof I; Smedby KE; Colvin K; Thanarajasingam G; Maurer MJ; Habermann TM; Song KW; Zhu KY; Gerrie AS; Cheah CY; El-Galaly TC
Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):581-586
Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors
Wadstrom H; Pettersson A; Smedby KE; Askling J
Article: CANCER CAUSES & CONTROL. 2020;31(5):451-462
Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study
Wade NB; Chang CM; Conti D; Millstein J; Skibola C; Nieters A; Wang SS; De Sanjose S; Kane E; Spinelli JJ; Bracci P; Zhang Y; Slager S; Wang J; Hjalgrim H; Smedby KE; Brown EE; Jarrett RF; Cozen W
Article: BRITISH JOURNAL OF CANCER. 2020;122(8):1242-1249
Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study
Hesla AC; Discacciati A; Tsagkozis P; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(1):106-116
Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study
Glimelius I; Smedby KE; Eloranta S; Jerkeman M; Weibull CE
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2020;51(8):789-800
Adult height in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study
Mouratidou N; Malmborg P; Sachs MC; Askling J; Ekbom A; Neovius M; Smedby KE; Savendahl L; Ludvigsson JF; Olen O
Article: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 2020;29(3):104560
Risk of Ischemic Stroke and Major Bleeding in Patients with Atrial Fibrillation and Cancer
Aspberg S; Yu L; Gigante B; Smedby KE; Singer DE
Article: GUT. 2020;69(3):453-461
Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964-2014
Olen O; Askling J; Sachs MC; Neovius M; Smedby KE; Ekbom A; Ludvigsson JF
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(3):682-691
Survival among solid organ transplant recipients diagnosed with cancer compared to nontransplanted cancer patients-A nationwide study
Benoni H; Eloranta S; Ekbom A; Wilczek H; Smedby KE
Article: HUMAN MOLECULAR GENETICS. 2020;29(1):70-79
Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways.
Kleinstern G; Yan H; Hildebrandt MAT; Vijai J; Berndt SI; Ghesquières H; McKay J; Wang SS; Nieters A; Ye Y; Monnereau A; Brooks-Wilson AR; Lan Q; Melbye M; Jackson RD; Teras LR; Purdue MP; Vajdic CM; Vermeulen RCH; Giles GG; Cocco PL; Birmann BM; Kraft P; Albanes D; Zeleniuch-Jacquotte A; Crouch S; Zhang Y; Sarangi V; Asmann Y; Offit K; Salles G; Wu X; Smedby KE; Skibola CF; Slager SL; Rothman N; Chanock SJ; Cerhan JR
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2020;29(1):119-126
Beta-Blocker Use and Lung Cancer Mortality in a Nationwide Cohort Study of Patients with Primary Non-Small Cell Lung Cancer
Udumyan R; Montgomery S; Fang F; Valdimarsdottir U; Hardardottir H; Ekbom A; Smedby KE; Fall K
Article: GENETIC EPIDEMIOLOGY. 2019;43(7):844-863
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes
Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadie M; Foretova L; Staines A; Mack TM; de Sanjose S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami H-O; Ghesquieres H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Doo NW; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud P-A; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
Article: INFLAMMATORY BOWEL DISEASES. 2019;25(10):1663-1673
Effects of Childhood-onset Inflammatory Bowel Disease on School Performance: A Nationwide Population-based Cohort Study Using Swedish Health and Educational Registers
Malmborg P; Mouratidou N; Sachs MC; Hammar U; Khalili H; Neovius M; Hjern A; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Olen O
Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(5):1200-1208
Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients
Weibull CE; Bjorkholm M; Glimelius I; Lambert PC; Andersson TML; Smedby KE; Dickman PW; Eloranta S
Article: CANCER MEDICINE. 2019;8(10):4918-4927
Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors-A population-based cohort study from Sweden and Denmark
Glimelius I; Englund A; Rostgaard K; Smedby KE; Eloranta S; Brown PDN; Johansen C; Kamper P; Ljungman G; Hjalgrim LL; Hjalgrim H
Article: BMC MEDICAL GENETICS. 2019;20(1):128
A multivariable approach for risk markers from pooled molecular data with only partial overlap
Stelzer A-S; Maccioni L; Gerhold-Ay A; Smedby KE; Schumacher M; Nieters A; Binder H
Article: SCIENCE TRANSLATIONAL MEDICINE. 2019;11(497):eaav5599
Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma
Jain N; Hartert K; Tadros S; Fiskus W; Havranek O; Ma MCJ; Bouska A; Heavican T; Kumar D; Deng Q; Moore D; Pak C; Liu CL; Gentles AJ; Hartmann E; Kridel R; Smedby KE; Juliusson G; Rosenquist R; Gascoyne RD; Rosenwald A; Giancotti F; Neelapu SS; Westin J; Vose JM; Lunning MA; Greiner T; Rodig S; Iqbal J; Alizadeh AA; Davis RE; Bhalla K; Green MR
Journal article: HEMASPHERE. 2019;3(S1):106-107
PF308 PROGNOSTIC FACTORS AND IMMUNOHISTOCHEMICAL PROFILE IN PRIMARY REFRACTORY AND RECURRENT DIFFUSE LARGE B‐CELL LYMPHOMAS
Lampikoski H; Drakos E; Nummisalo E; Tzoras E; Kokaraki G; Harrysson S; Smedby KE; Rassidakis G
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(3):207-212
Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjogren's syndrome
Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Ronnblom L; Sundstrom C; Baecklund E
Article: JOURNAL OF INTERNAL MEDICINE. 2019;285(4):455-468
Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study
Wasterlid T; Mohammadi M; Smedby KE; Glimelius I; Jerkeman M; Bottai M; Eloranta S
Article: HAEMATOLOGICA. 2019;104(2):360-369
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
Baliakas P; Moysiadis T; Hadzidimitriou A; Xochelli A; Jeromin S; Agathangelidis A; Mattsson M; Sutton L-A; Minga E; Scarfo L; Rossi D; Davis Z; Villamor N; Parker H; Kotaskova J; Stalika E; Plevova K; Mansouri L; Cortese D; Navarro A; Delgado J; Larrayoz M; Young E; Anagnostopoulos A; Smedby KE; Juliusson G; Sheehy O; Catherwood M; Strefford JC; Stavroyianni N; Belessi C; Pospisilova S; Oscier D; Gaidano G; Campo E; Haferlach C; Ghia P; Rosenquist R; Stamatopoulos K
Article: GASTROENTEROLOGY. 2019;156(3):614-622
Increased Mortality of Patients With Childhood- Onset Inflammatory Bowel Diseases, Compared With the General Population
Olen O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
Article: CLINICAL EPIDEMIOLOGY. 2019;11:1025-1034
Cardiovascular Diseases And Psychiatric Disorders During The Diagnostic Workup Of Suspected Hematological Malignancy
Liu Q; Andersson TM; Joud A; Shen Q; Schelin MEC; Magnusson PKE; Smedby KE; Fang F
Article: FRONTIERS IN ONCOLOGY. 2019;9:1539
Genetically Determined Height and Risk of Non-hodgkin Lymphoma
Moore A; Kane E; Wang Z; Panagiotou OA; Teras LR; Monnereau A; Wong Doo N; Machiela MJ; Skibola CF; Slager SL; Salles G; Camp NJ; Bracci PM; Nieters A; Vermeulen RCH; Vijai J; Smedby KE; Zhang Y; Vajdic CM; Cozen W; Spinelli JJ; Hjalgrim H; Giles GG; Link BK; Clavel J; Arslan AA; Purdue MP; Tinker LF; Albanes D; Ferri GM; Habermann TM; Adami H-O; Becker N; Benavente Y; Bisanzi S; Boffetta P; Brennan P; Brooks-Wilson AR; Canzian F; Conde L; Cox DG; Curtin K; Foretova L; Gapstur SM; Ghesquieres H; Glenn M; Glimelius B; Jackson RD; Lan Q; Liebow M; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Morton LM; North KE; Offit K; Padoan M; Patel AV; Piro S; Ravichandran V; Riboli E; de Sanjose S; Severson RK; Southey MC; Staines A; Stewart C; Travis RC; Weiderpass E; Weinstein S; Zheng T; Chanock SJ; Chatterjee N; Rothman N; Birmann BM; Cerhan JR; Berndt SI
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2019;184(2):192-201
High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms
Gholiha AR; Hollander P; Hedstrom G; Sundstrom C; Molin D; Smedby KE; Hjalgrim H; Glimelius I; Amini R-M; Enblad G
Article: BLOOD CANCER JOURNAL. 2018;9(1):1
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
Went M; Sud A; Speedy H; Sunter NJ; Foersti A; Law PJ; Johnson DC; Mirabella F; Holroyd A; Li N; Orlando G; Weinhold N; van Duin M; Chen B; Mitchell JS; Mansouri L; Juliusson G; Smedby KE; Jayne S; Majid A; Dearden C; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Kuiper R; Stephens OW; Bertsch U; Broderick P; Einsele H; Gregory WM; Hillengass J; Hoffmann P; Jackson GH; Joeckel K-H; Nickel J; Noethen MM; da Silva Filho MI; Thomsen H; Walker BA; Broyl A; Davies FE; Hansson M; Goldschmidt H; Dyer MJS; Kaiser M; Sonneveld P; Morgan GJ; Hemminki K; Nilsson B; Catovsky D; Allan JM; Houlston RS
Article: JCO CLINICAL CANCER INFORMATICS. 2018;2:1-13
Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study
Biccler JL; Eloranta S; Brown PDN; Frederikseri H; Jerkeman M; Jorgensen J; Jakobsen LH; Smedby KE; Bogsted M; El-Galaly TC
Article: BREAST CANCER RESEARCH. 2018;20(1):142
No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Article: NATURE COMMUNICATIONS. 2018;9(1):4182
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenstrom macroglobulinemia
McMaster ML; Berndt SI; Zhang J; Slager SL; Li SA; Vajdic CM; Smedby KE; Yan H; Birmann BM; Brown EE; Smith A; Kleinstern G; Fansler MM; Mayr C; Zhu B; Chung CC; Park J-H; Burdette L; Hicks BD; Hutchinson A; Teras LR; Adami H-O; Bracci PM; McKay J; Monnereau A; Link BK; Vermeulen RCH; Ansell SM; Maria A; Diver WR; Melbye M; Ojesina AI; Kraft P; Boffetta P; Clavel J; Giovannucci E; Besson CM; Canzia F; Travis RC; Vineis P; Weiderpass E; Montalvan R; Wang Z; Yeager M; Becker N; Benavente Y; Brennan P; Foretova L; Maynadie M; Nieters A; de Sanjose S; Staines A; Conde L; Riby J; Glimelius B; Hjalgrim H; Pradhan N; Feldman AL; Novak AJ; Lawrence C; Bassig BA; Lan Q; Zheng T; North KE; Tinker LF; Cozen W; Severson RK; Hofmann JN; Zhang Y; Jackson RD; Morton LM; Purdue MP; Chatterjee N; Offit K; Cerhan JR; Chanock SJ; Rothman N; Vijai J; Goldin LR; Skibola CF; Caporaso NE
Article: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(26):2718-2725
Contemporarily Treated Patients With Hodgkin Lymphoma Have Childbearing Potential in Line With Matched Comparators
Weibull CE; Johansson ALV; Eloranta S; Smedby KE; Bjorkholm M; Lambert PC; Dickman PW; Glimelius I
Article: CANCER RESEARCH. 2018;78(14):4086-4096
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes
Wang SS; Carrington M; Berndt SI; Slager SL; Bracci PM; Voutsinas J; Cerhan JR; Smedby KE; Hjalgrim H; Vijai J; Morton LM; Vermeulen R; Paltiel O; Vajdic CM; Linet MS; Nieters A; de Sanjose S; Cozen W; Brown EE; Turner J; Spinelli JJ; Zheng T; Birmann BM; Flowers CR; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Albanes D; Weinstein SJ; Teras LR; Diver WR; Lax SJ; Travis RC; Kaaks R; Riboli E; Benavente Y; Brennan P; McKay J; Delfau-Larue M-H; Link BK; Magnani C; Ennas MG; Latte G; Feldman AL; Doo NW; Giles GG; Southey MC; Milne RL; Offit K; Musinsky J; Arslan AA; Purdue MP; Adami H-O; Melbye M; Glimelius B; Conde L; Camp NJ; Glenn M; Curtin K; Clavel J; Monnereau A; Cox DG; Ghesquieres H; Salles G; Bofetta P; Foretova L; Staines A; Davis S; Severson RK; Lan Q; Brooks-Wilson A; Smith MT; Roman E; Kricker A; Zhang Y; Kraft P; Chanock SJ; Rothman N; Hartge P; Skibola CF
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(4):270-275
Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis
Baecklund E; Backlin C; Ronnelid J; Toes R; Huizinga TWJ; Ahlin E; Askling J; Hochberg FH; Klareskog L; Kay J; Smedby KE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;101(1):106-114
Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphomaA population-based study from Sweden
Bjorkholm M; Weibull CE; Eloranta S; Smedby KE; Glimelius I; Dickman PW
Article: BLOOD. 2018;131(23):2541-2551
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Kleinstern G; Camp NJ; Goldin LR; Vachon CM; Vajdic CM; de Sanjose S; Weinberg JB; Benavente Y; Casabonne D; Liebow M; Nieters A; Hjalgrim H; Melbye M; Glimelius B; Adami H-O; Boffetta P; Brennan P; Maynadie M; McKay J; Cocco PL; Shanafelt TD; Call TG; Norman AD; Hanson C; Robinson D; Chaffee KG; Brooks-Wilson AR; Monnereau A; Clavel J; Glenn M; Curtin K; Conde L; Bracci PM; Morton LM; Cozen W; Severson RK; Chanock SJ; Spinelli JJ; Johnston JB; Rothman N; Skibola CF; Leis JF; Kay NE; Smedby KE; Berndt SI; Cerhan JR; Caporaso N; Slager SL
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2018;93(8):1020-1028
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma
Ekberg S; Jerkeman M; Andersson P-O; Enblad G; Wahlin BE; Hasselblom S; Andersson TM; Eloranta S; Smedby KE
Article: HUMAN MOLECULAR GENETICS. 2018;27(10):1809-1818
A genome-wide association study of IgM antibody against phosphorylcholine: shared genetics and phenotypic relationship to chronic lymphocytic leukemia
Chen X; Gustafsson S; Whitington T; Borne Y; Lorentzen E; Sun J; Almgren P; Su J; Karlsson R; Song J; Lu Y; Zhan Y; Hagg S; Svensson P; Smedby KE; Slager SL; Ingelsson E; Lindgren CM; Morris AP; Melander O; Karlsson T; de Faire U; Caidahl K; Engstrom G; Lind L; Karlsson MCI; Pedersen NL; Frostegard J; Magnusson PKE
Article: RADIOTHERAPY AND ONCOLOGY. 2018;126(3):424-430
Short- and long-term risks of cardiovascular disease following radiotherapy in rectal cancer in four randomized controlled trials and a population-based register
Chen L; Eloranta S; Martling A; Glimelius I; Neovius M; Glimelius B; Smedby KE
Article: ACTA ONCOLOGICA. 2018;57(2):276-282
Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome
Englund A; Glimelius I; Rostgaard K; Smedby KE; Eloranta S; Molin D; Kuusk T; Brown PDN; Kamper P; Hjalgrim H; Ljungman G; Hjalgrim LL
Article: JOURNAL OF CROHNS & COLITIS. 2018;12(2):157-166
Surgical Treatment in Childhood-onset Inflammatory Bowel Disease-A Nationwide Register-based Study of 4695 Incident Patients in Sweden 2002-2014
Nordenvall C; Rosvall O; Bottai M; Everhov AH; Malmborg P; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Myrelid P; Olen O
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(1):88-97
An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome
Hollander P; Rostgaard K; Smedby KE; Molin D; Loskog A; Brown PDN; Enblad G; Amini R-M; Hjalgrim H; Glimelius I
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(1):61-68
Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013
Eloranta S; Branvall E; Celsing F; Papworth K; Ljungqvist M; Enblad G; Ekstrom-Smedby K
Article: CANCER MEDICINE. 2018;7(1):114-122
Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI
Biccler J; Eloranta S; Brown PDN; Frederiksen H; Jerkeman M; Smedby KE; Bogsted M; El-Galaly TC
Article: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(36):4019-4026
International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma.
Maurer MJ; Ellin F; Srour L; Jerkeman M; Bennani NN; Connors JM; Slack GW; Smedby KE; Ansell SM; Link BK; Cerhan JR; Relander T; Savage KJ; Feldman AL
Article: BREAST CANCER RESEARCH AND TREATMENT. 2017;166(3):887-896
Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
Frisk G; Tinge B; Ekberg S; Eloranta S; Backlund LM; Lidbrink E; Smedby KE
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;186(10):1159-1167
Parental Age and Risk of Lymphoid Neoplasms
Larfors G; Glimelius I; Eloranta S; Smedby KE
Article: INTERNATIONAL JOURNAL OF CANCER. 2017;141(7):1345-1354
Primary tumor sites in relation to ultraviolet radiation exposure and skin visibility correlate with survival in cutaneous melanoma
Gordon D; Hansson J; Eloranta S; Gordon M; Gillgren P; Smedby KE
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2017;109(10):djx041
Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients
He W; Smedby KE; Fang F; Olsson H; Margolin S; Hall P; Czene K
Article: BMJ-BRITISH MEDICAL JOURNAL. 2017;358:j3951
Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014
Olen O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
Article: CLINICAL CANCER RESEARCH. 2017;23(17):5292-5301
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
Xochelli A; Baliakas P; Kavakiotis I; Agathangelidis A; Sutton L-A; Minga E; Ntoufa S; Tausch E; Yan X-J; Shanafelt T; Plevova K; Boudjogra M; Rossi D; Davis Z; Navarro A; Sandberg Y; Vojdeman FJ; Scarfo L; Stavroyianni N; Sudarikov A; Veronese S; Tzenou T; Karan-Djurasevic T; Catherwood M; Kienle D; Chatzouli M; Facco M; Bahlo J; Pott C; Pedersen LB; Mansouri L; Smedby KE; Chu CC; Giudicelli V; Lefranc M-P; Panagiotidis P; Juliusson G; Anagnostopoulos A; Vlahavas I; Antic D; Trentin L; Montillo M; Niemann C; Doehner H; Langerak AW; Pospisilova S; Hallek M; Campo E; Chiorazzi N; Maglaveras N; Oscier D; Gaidano G; Jelinek DF; Stilgenbauer S; Chouvarda I; Darzentas N; Belessi C; Davi F; Hadzidimitriou A; Rosenquist R; Ghia P; Stamatopoulos K
Article: BLOOD ADVANCES. 2017;1(18):1427-1439
High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome
Hollander P; Kamper P; Smedby KE; Enblad G; Ludvigsen M; Mortensen J; Amini R-M; Hamilton-Dutoit S; d'Amore F; Molin D; Glimelius I
Journal article: CANCER RESEARCH. 2017;77(13_Supplement):1318
Abstract 1318: A genome-wide association study of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma demonstrates association with chromosome 6
McMaster ML; Berndt SI; Li SA; Slager S; Vijai J; Chung CC; Zhu B; Burdette L; Birmann B; Brown EE; Cerhan JR; Ekstrom-Smedby K; Hjalgrim H; Kleinstern G; Link BK; McKay J; Monnereau A; Morton LM; Nieters A; Rothman N; Skibola CF; Smith A; Teras LR; Vajdic CM; Vermeulen R; Hicks B; Goldin LR; Caporaso NE
Article: LEUKEMIA. 2017;31(7):1547-1554
EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia
Young E; Noerenberg D; Mansouri L; Ljungstrom V; Frick M; Sutton L-A; Blakemore SJ; Galan-Sousa J; Plevova K; Baliakas P; Rossi D; Clifford R; Roos-Weil D; Navrkalova V; Doerken B; Schmitt CA; Smedby KE; Juliusson G; Giacopelli B; Blachly JS; Belessi C; Panagiotidis P; Chiorazzi N; Davi F; Langerak AW; Oscier D; Schuh A; Gaidano G; Ghia P; Xu W; Fan L; Bernard OA; Nguyen-Khac F; Rassenti L; Li J; Kipps TJ; Stamatopoulos K; Pospisilova S; Zenz T; Oakes CC; Strefford JC; Rosenquist R; Damm F
Article: CANCER RESEARCH. 2017;77(13):3700-3707
Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma
Udumyan R; Montgomery S; Fang F; Almroth H; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):100-101
UNMET MEDICAL NEEDS IN HODGKIN LYMPHOMA WITH SPECIAL FOCUS ON THE ELDERLY – a POPULATION‐BASED STUDY OF PATIENTS DIAGNOSED IN SWEDEN 1973‐2014
Bjorkholm M; Weibull CE; Eloranta S; Ekström‐Smedby K; Glimelius I; Dickman PW
Article: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(14):1522-1529
Maternal Cancer During Pregnancy and Risks of Stillbirth and Infant Mortality
Lu D; Ludvigsson JF; Smedby KE; Fall K; Valdimarsdottir U; Cnattingius S; Fang F
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;185(8):681-687
Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma
Baecklund F; Foo J-N; Askling J; Eloranta S; Glimelius I; Liu J; Hjalgrim H; Rosenquist R; Padyukov L; Smedby KE
Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(4):700-708
Rheumatoid Arthritis and Risk of Malignant Lymphoma
Hellgren K; Baecklund E; Backlin C; Sundstrom C; Smedby KE; Askling J
Article: SCIENTIFIC REPORTS. 2017;7(1):67
Patterns of acute inflammatory symptoms prior to cancer diagnosis
Setiawan A; Yin L; Auer G; Czene K; Smedby KE; Pawitan Y
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2017;92(3):251-258
Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy
Glimelius I; Eloranta S; Ekberg S; Chang ET; Neovius M; Smedby KE
Article: NATURE COMMUNICATIONS. 2017;8:14175
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Law PJ; Berndt SI; Speedy HE; Camp NJ; Sava GP; Skibola CF; Holroyd A; Joseph V; Sunter NJ; Nieters A; Bea S; Monnereau A; Martin-Garcia D; Goldin LR; Clot G; Teras LR; Quintela I; Birmann BM; Jayne S; Cozen W; Majid A; Smedby KE; Lan Q; Dearden C; Brooks-Wilson AR; Hall AG; Purdue MP; Mainou-Fowler T; Vajdic CM; Jackson GH; Cocco P; Marr H; Zhang Y; Zheng T; Giles GG; Lawrence C; Call TG; Liebow M; Melbye M; Glimelius B; Mansouri L; Glenn M; Curtin K; Diver WR; Link BK; Conde L; Bracci PM; Holly EA; Jackson RD; Tinker LF; Benavente Y; Boffetta P; Brennan P; Maynadie M; McKay J; Albanes D; Weinstein S; Wang Z; Caporaso NE; Morton LM; Severson RK; Riboli E; Vineis P; Vermeulen RCH; Southey MC; Milne RL; Clavel J; Topka S; Spinelli JJ; Kraft P; Ennas MG; Summerfield G; Ferri GM; Harris RJ; Miligi L; Pettitt AR; North KE; Allsup DJ; Fraumeni JFJ; Bailey JR; Offit K; Pratt G; Hjalgrim H; Pepper C; Chanock SJ; Fegan C; Rosenquist R; de Sanjose S; Carracedo A; Dyer MJS; Catovsky D; Campo E; Cerhan JR; Allan JM; Rothman N; Houlston R; Slager SL
Article: BRITISH JOURNAL OF SURGERY. 2017;104(3):278-287
Risk of second primary cancer in patients treated with radiotherapy for rectal cancer
Martling A; Smedby KE; Birgisson H; Olsson H; Granath F; Ekbom A; Glimelius B
Article: BMC GASTROENTEROLOGY. 2017;17(1):23
Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study
Ludvigsson JF; Busch K; Olen O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
Article: LUPUS SCIENCE & MEDICINE. 2017;4(1):e000187
Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma.
Bernatsky S; Velásquez García HA; Spinelli JJ; Gaffney P; Smedby KE; Ramsey-Goldman R; Wang SS; Adami H-O; Albanes D; Angelucci E; Ansell SM; Asmann YW; Becker N; Benavente Y; Berndt SI; Bertrand KA; Birmann BM; Boeing H; Boffetta P; Bracci PM; Brennan P; Brooks-Wilson AR; Cerhan JR; Chanock SJ; Clavel J; Conde L; Cotenbader KH; Cox DG; Cozen W; Crouch S; De Roos AJ; de Sanjose S; Di Lollo S; Diver WR; Dogan A; Foretova L; Ghesquières H; Giles GG; Glimelius B; Habermann TM; Haioun C; Hartge P; Hjalgrim H; Holford TR; Holly EA; Jackson RD; Kaaks R; Kane E; Kelly RS; Klein RJ; Kraft P; Kricker A; Lan Q; Lawrence C; Liebow M; Lightfoot T; Link BK; Maynadie M; McKay J; Melbye M; Molina TJ; Monnereau A; Morton LM; Nieters A; North KE; Novak AJ; Offit K; Purdue MP; Rais M; Riby J; Roman E; Rothman N; Salles G; Severi G; Severson RK; Skibola CF; Slager SL; Smith A; Smith MT; Southey MC; Staines A; Teras LR; Thompson CA; Tilly H; Tinker LF; Tjonneland A; Turner J; Vajdic CM; Vermeulen RCH; Vijai J; Vineis P; Virtamo J; Wang Z; Weinstein S; Witzig TE; Zelenetz A; Zeleniuch-Jacquotte A; Zhang Y; Zheng T; Zucca M; Clarke AE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(4):614-622
Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study
Melen CM; Enblad G; Sonnevi K; Junlen HR; Smedby KE; Jerkeman M; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(3):410-418
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau
Eskelund CW; Kolstad A; Jerkeman M; Raty R; Laurell A; Eloranta S; Smedby KE; Husby S; Pedersen LB; Andersen NS; Eriksson M; Kimby E; Bentzen H; Kuittinen O; Lauritzsen GF; Nilsson-Ehle H; Ralfkiaer E; Ehinger M; Sundstrom C; Delabie J; Karjalainen-Lindsberg M-L; Workman CT; Garde C; Elonen E; Brown P; Gronbaek K; Geisler CH
Article: EPIGENETICS. 2016;11(6):449-455
Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2
Bhoi S; Ljungstrom V; Baliakas P; Mattsson M; Smedby KE; Juliusson G; Rosenquist R; Mansouri L
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2016;45(3):728-740
Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.
Khankhanian P; Cozen W; Himmelstein DS; Madireddy L; Din L; van den Berg A; Matsushita T; Glaser SL; Moré JM; Smedby KE; Baranzini SE; Mack TM; Lizée A; de Sanjosé S; Gourraud P-A; Nieters A; Hauser SL; Cocco P; Maynadié M; Foretová L; Staines A; Delahaye-Sourdeix M; Li D; Bhatia S; Melbye M; Onel K; Jarrett R; McKay JD; Oksenberg JR; Hjalgrim H
Article: GASTROENTEROLOGY. 2016;150(7):1561-1567.e1
Association Between Long-term Oral Contraceptive Use and Risk of Crohn's Disease Complications in a Nationwide Study
Khalili H; Granath F; Smedby KE; Ekbom A; Neovius M; Chan AT; Olen O
Article: JOURNAL OF CANCER SURVIVORSHIP. 2016;10(3):514-523
Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse
Everhov AH; Ekberg S; Hirschberg AL; Bergmark K; Radestad AF; Glimelius I; Smedby KE
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2016;25(6):987-994
Work Loss Duration and Predictors Following Rectal Cancer Treatment among Patients with and without Prediagnostic Work Loss
Chen L; Glimelius I; Neovius M; Ekberg S; Martling A; Eloranta S; Smedby KE
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2016;51(5):583-589
Risk of lymphoid neoplasms in a Swedish population-based cohort of 337,437 patients undergoing appendectomy
Mohammadi M; Song H; Cao Y; Glimelius I; Ekbom A; Ye W; Smedby KE
Article: HUMAN MOLECULAR GENETICS. 2016;25(8):1663-1676
Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes
Machiela MJ; Lan Q; Slager SL; Vermeulen RCH; Teras LR; Camp NJ; Cerhan JR; Spinelli JJ; Wang SS; Nieters A; Vijai J; Yeager M; Wang Z; Ghesquieres H; Mckay J; Conde L; de Bakker PIW; Cox DG; Burdett L; Monnereau A; Flowers CR; De Roos AJ; Brooks-Wilson AR; Giles GG; Melbye M; Gu J; Jackson RD; Kane E; Purdue MP; Vajdic CM; Albanes D; Kelly RS; Zucca M; Bertrand KA; Zeleniuch-Jacquotte A; Lawrence C; Hutchinson A; Zhi D; Habermann TM; Link BK; Novak AJ; Dogan A; Asmann YW; Liebow M; Thompson CA; Ansell SM; Witzig TE; Tilly H; Haioun C; Molina TJ; Hjalgrim H; Glimelius B; Adami H-O; Roos G; Bracci PM; Riby J; Smith MT; Holly EA; Cozen W; Hartge P; Morton LM; Severson RK; Tinker LF; North KE; Becker N; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; Lightfoot T; Crouch S; Smith A; Roman E; Diver WR; Offit K; Zelenetz A; Klein RJ; Villano DJ; Zheng T; Zhang Y; Holford TR; Turner J; Southey MC; Clavel J; Virtamo J; Weinstein S; Riboli E; Vineis P; Kaaks R; Boeing H; Tjonneland A; Angelucci E; Di Lollo S; Rais M; De Vivo I; Giovannucci E; Kraft P; Huang J; Ma B; Ye Y; Chiu BCH; Liang L; Park J-H; Chung CC; Weisenburger DD; Fraumeni JFJ; Salles G; Glenn M; Cannon-Albright L; Curtin K; Wu X; Smedby KE; de Sanjose S; Skibola CF; Berndt SI; Birmann BM; Chanock SJ; Rothman N
Article: NATURE COMMUNICATIONS. 2016;7:10933
Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
Berndt SI; Camp NJ; Skibola CF; Vijai J; Wang Z; Gu J; Nieters A; Kelly RS; Smedby KE; Monnereau A; Cozen W; Cox A; Wang SS; Lan Q; Teras LR; Machado M; Yeager M; Brooks-Wilson AR; Hartge P; Purdue MP; Birmann BM; Vajdic CM; Cocco P; Zhang Y; Giles GG; Zeleniuch-Jacquotte A; Lawrence C; Montalvan R; Burdett L; Hutchinson A; Ye Y; Call TG; Shanafelt TD; Novak AJ; Kay NE; Liebow M; Cunningham JM; Allmer C; Hjalgrim H; Adami H-O; Melbye M; Glimelius B; Chang ET; Glenn M; Curtin K; Cannon-Albright LA; Diver WR; Link BK; Weiner GJ; Conde L; Bracci PM; Riby J; Arnett DK; Zhi D; Leach JM; Holly EA; Jackson RD; Tinker LF; Benavente Y; Sala N; Casabonne D; Becker N; Boffetta P; Brennan P; Foretova L; Maynadie M; McKay J; Staines A; Chaffee KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Leis JF; Weinberg JB; Caporaso NE; Norman AD; De Roos AJ; Morton LM; Severson RK; Riboli E; Vineis P; Kaaks R; Masala G; Weiderpass E; Chirlaque M-D; Vermeulen RCH; Travis RC; Southey MC; Milne RL; Albanese D; Virtamo J; Weinstein S; Clavel J; Zheng T; Holford TR; Villano DJ; Maria A; Spinelli JJ; Gascoyne RD; Connors JM; Bertrand KA; Giovannucci E; Kraft P; Kricker A; Turner J; Ennas MG; Ferri GM; Miligi L; Liang L; Ma B; Huang J; Crouch S; Park J-H; Chatterjee N; North KE; Snowden JA; Wright J; Fraumeni JF; Offit K; Wu X; de Sanjose S; Cerhan JR; Chanock SJ; Rothman N; Slager SL
Article: JOURNAL OF SEXUAL MEDICINE. 2016;13(3):413-424
Serum Androgen Levels and Sexual Function Before and One Year After Treatment of Uterine Cervical Cancer: A Pilot Study
Everhov AH; Radestad AF; Nyberg T; Smedby KE; Bergmark K; Hirschberg AL
Article: BLOOD. 2016;127(8):1007-1016
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
Ljungstrom V; Cortese D; Young E; Pandzic T; Mansouri L; Plevova K; Ntoufa S; Baliakas P; Clifford R; Sutton L-A; Blakemore SJ; Stavroyianni N; Agathangelidis A; Rossi D; Hoglund M; Kotaskova J; Juliusson G; Belessi C; Chiorazzi N; Panagiotidis P; Langerak AW; Smedby KE; Oscier D; Gaidano G; Schuh A; Davi F; Pott C; Strefford JC; Trentin L; Pospisilova S; Ghia P; Stamatopoulos K; Sjoblom T; Rosenquist R
Article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(4):337-344
Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma
Weibull CE; Eloranta S; Smedby KE; Bjorkholm M; Kristinsson SY; Johansson ALV; Dickman PW; Glimelius I
Article: BRITISH JOURNAL OF DERMATOLOGY. 2016;174(1):95-103
Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study
Krynitz B; Olsson H; Rozell BL; Lindelof B; Edgren G; Smedby KE
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2015;107(12):djv279
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types
Sampson JN; Wheeler WA; Yeager M; Panagiotou O; Wang Z; Berndt SI; Lan Q; Abnet CC; Amundadottir LT; Figueroa JD; Landi MT; Mirabello L; Savage SA; Taylor PR; De Vivo I; McGlynn KA; Purdue MP; Rajaraman P; Adami H-O; Ahlbom A; Albanes D; Amary MF; An S-J; Andersson U; Andriole GJ; Andrulis IL; Angelucci E; Ansell SM; Arici C; Armstrong BK; Arslan AA; Austin MA; Baris D; Barkauskas DA; Bassig BA; Becker N; Benavente Y; Benhamou S; Berg C; Van Den Berg D; Bernstein L; Bertrand KA; Birmann BM; Black A; Boeing H; Boffetta P; Boutron-Ruault M-C; Bracci PM; Brinton L; Brooks-Wilson AR; Bueno-de-Mesquita HB; Burdett L; Buring J; Butler MA; Cai Q; Cancel-Tassin G; Canzian F; Carrato A; Carreon T; Carta A; Chan JKC; Chang ET; Chang G-C; Chang I-S; Chang J; Chang-Claude J; Chen C-J; Chen C-Y; Chen C; Chen C-H; Chen C; Chen H; Chen K; Chen K-Y; Chen K-C; Chen Y; Chen Y-H; Chen Y-S; Chen Y-M; Chien L-H; Chirlaque M-D; Choi JE; Choi YY; Chow W-H; Chung CC; Clavel J; Clavel-Chapelon F; Cocco P; Colt JS; Comperat E; Conde L; Connors JM; Conti D; Cortessis VK; Cotterchio M; Cozen W; Crouch S; Crous-Bou M; Cussenot O; Davis FG; Ding T; Diver WR; Dorronsoro M; Dossus L; Duell EJ; Ennas MG; Erickson RL; Feychting M; Flanagan AM; Foretova L; Fraumeni JFJ; Freedman ND; Freeman LEB; Fuchs C; Gago-Dominguez M; Gallinger S; Gao Y-T; Gapstur SM; Garcia-Closas M; Garcia-Closas R; Gascoyne RD; Gastier-Foster J; Gaudet MM; Gaziano JM; Giffen C; Giles GG; Giovannucci E; Glimelius B; Goggins M; Gokgoz N; Goldstein AM; Gorlick R; Gross M; Grubb RIII; Gu J; Guan P; Gunter M; Guo H; Habermann TM; Haiman CA; Halai D; Hallmans G; Hassan M; Hattinger C; He Q; He X; Helzlsouer K; Henderson B; Henriksson R; Hjalgrim H; Hoffman-Bolton J; Hohensee C; Holford TR; Holly EA; Hong Y-C; Hoover RN; Horn-Ross PL; Hosain GMM; Hosgood HDIII; Hsiao C-F; Hu N; Hu W; Hu Z; Huang M-S; Huerta J-M; Hung J-Y; Hutchinson A; Inskip PD; Jackson RD; Jacobs EJ; Jenab M; Jeon H-S; Ji B-T; Jin G; Jin L; Johansen C; Johnson A; Jung YJ; Kaaks R; Kamineni A; Kane E; Kang CH; Karagas MR; Kelly RS; Khaw K-T; Kim C; Kim HN; Kim JH; Kim JS; Kim YH; Kim YT; Kim Y-C; Kitahara CM; Klein AP; Klein RJ; Kogevinas M; Kohno T; Kolonel LN; Kooperberg C; Kricker A; Krogh V; Kunitoh H; Kurtz RC; Kweon S-S; LaCroix A; Lawrence C; Lecanda F; Lee VHF; Li D; Li H; Li J; Li Y-J; Li Y; Liao LM; Liebow M; Lightfoot T; Lim W-Y; Lin C-C; Lin D; Lindstrom S; Linet MS; Link BK; Liu C; Liu J; Liu L; Ljungberg B; Lloreta J; Di Lollo S; Lu D; Lund E; Malats N; Mannisto S; Le Marchand L; Marina N; Masala G; Mastrangelo G; Matsuo K; Maynadie M; Mckay J; McKean-Cowdin R; Melbye M; Melin BS; Michaud DS; Mitsudomi T; Monnereau A; Montalvan R; Moore LE; Mortensen LM; Nieters A; North KE; Novak AJ; Oberg AL; Offit K; Oh I-J; Olson SH; Palli D; Pao W; Park IK; Park JY; Park KH; Patino-Garcia A; Pavanello S; Peeters PHM; Perng R-P; Peters U; Petersen GM; Picci P; Pike MC; Porru S; Prescott J; Prokunina-Olsson L; Qian B; Qiao Y-L; Rais M; Riboli E; Riby J; Risch HA; Rizzato C; Rodabough R; Roman E; Roupret M; Ruder AM; de Sanjose S; Scelo G; Schned A; Schumacher F; Schwartz K; Schwenn M; Scotlandi K; Seow A; Serra C; Serra M; Sesso HD; Setiawan VW; Severi G; Severson RK; Shanafelt TD; Shen H; Shen W; Shin M-H; Shiraishi K; Shu X-O; Siddiq A; Sierrasesumaga L; Sihoe ADL; Skibola CF; Smith A; Smith MT; Southey MC; Spinelli JJ; Staines A; Stampfer M; Stern MC; Stevens VL; Stolzenberg-Solomon RS; Su J; Su W-C; Sund M; Sung JS; Sung SW; Tan W; Tang W; Tardon A; Thomas D; Thompson CA; Tinker LF; Tirabosco R; Tjonneland A; Travis RC; Trichopoulos D; Tsai F-Y; Tsai Y-H; Tucker M; Turner J; Vajdic CM; Vermeulen RCH; Villano DJ; Vineis P; Virtamo J; Visvanathan K; Wactawski-Wende J; Wang C; Wang C-L; Wang J-C; Wang J; Wei F; Weiderpass E; Weiner GJ; Weinstein S; Wentzensen N; White E; Witzig TE; Wolpin BM; Wong MP; Wu C; Wu G; Wu J; Wu T; Wu W; Wu X; Wu Y-L; Wunder JS; Xiang Y-B; Xu J; Xu P; Yang P-C; Yang T-Y; Ye Y; Yin Z; Yokota J; Yoon H-I; Yu C-J; Yu H; Yu K; Yuan J-M; Zelenetz A; Zeleniuch-Jacquotte A; Zhang X-C; Zhang Y; Zhao X; Zhao Z; Zheng H; Zheng T; Zheng W; Zhou B; Zhu M; Zucca M; Boca SM; Cerhan JR; Ferri GM; Hartge P; Hsiung CA; Magnani C; Miligi L; Morton LM; Smedby KE; Teras LR; Vijai J; Wang SS; Brennan P; Caporaso NE; Hunter DJ; Kraft P; Rothman N; Silverman DT; Slager SL; Chanock SJ; Chatterjee N
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2015;24(12):1838-1843
A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma
Delahaye-Sourdeix M; Urayama KY; Gaborieau V; Veenstra R; Foll M; Chabrier A; Benavente Y; Nieters A; Becker N; Foretova L; Maynadie M; Staines A; Smedby KE; Glimelius I; Lightfoot T; Cocco P; Galan P; Vatten LJ; Duell EJ; Kiemeney L; Roman E; de Sanjose S; Lathrop M; Melbye M; Brennan P; Diepstra A; Van den Berg A; Hjalgrim H; Jarrett RF; McKay JD
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2015;90(12):1128-1134
Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics
Glimelius I; Ekberg S; Jerkeman M; Chang ET; Bjorkholm M; Andersson TML; Smedby KE; Eloranta S
Article: JOURNAL OF CANCER SURVIVORSHIP. 2015;9(4):599-609
Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study
Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
Article: ACTA ONCOLOGICA. 2015;54(10):1770-1780
Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment
Nord C; Olofsson S-E; Glimelius I; Cedermark GC; Ekberg S; Cavallin-Stahl E; Neovius M; Jerkeman M; Smedby KE
Article: BMC CANCER. 2015;15:850
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study
Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
Article: EUROPEAN JOURNAL OF CANCER PREVENTION. 2015;24(6):535-541
Maternal and birth anthropometric characteristics in relation to the risk of childhood lymphomas: a Swedish nationwide cohort study
Petridou ET; Sergentanis TN; Skalkidou A; Antonopoulos CN; Dessypris N; Svensson T; Stephansson O; Kieler H; Smedby KE
Article: COLORECTAL DISEASE. 2015;17(10):882-890
Probability, rate and timing of reconstructive surgery following colectomy for inflammatory bowel disease in Sweden: a population-based cohort study
Nordenvall C; Myrelid P; Ekbom A; Bottai M; Smedby KE; Olen O; Nilsson PJ
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2015;182(7):624-632
Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma
Hollander P; Rostgaard K; Smedby KE; Chang ET; Amini R-M; Brown PDN; Glimelius B; Adami H-O; Melbye M; Glimelius I; Hjalgrim H
Article: BRITISH JOURNAL OF SURGERY. 2015;102(11):1426-1432
Risk of disability pension in patients following rectal cancer treatment and surgery
Chen L; Glimelius I; Neovius M; Eloranta S; Ekberg S; Martling A; Smedby KE
Article: MELANOMA RESEARCH. 2015;25(4):348-356
Time trends in incidence of cutaneous melanoma by detailed anatomical location and patterns of ultraviolet radiation exposure: a retrospective population-based study
Gordon D; Gillgren P; Eloranta S; Olsson H; Gordon M; Hansson J; Smedby KE
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2015;24(7):1061-1070
Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.
Kane E; Skibola CF; Bracci PM; Cerhan JR; Costas L; Smedby KE; Holly EA; Maynadié M; Novak AJ; Lightfoot TJ; Ansell SM; Smith AG; Liebow M; Melbye M; Morton L; de Sanjosé S; Slager SL; Wang SS; Zhang Y; Zheng T; Roman E
Article: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2015;73(1):106-113.e2
Cutaneous malignant melanoma in the Swedish organ transplantation cohort: A study of clinicopathological characteristics and mortality
Krynitz B; Rozell BL; Lyth J; Smedby KE; Lindelof B
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2015;212(6):833-843
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia
Mansouri L; Sutton L-A; Ljungstrom V; Bondza S; Arngarden L; Bhoi S; Larsson J; Cortese D; Kalushkova A; Plevova K; Young E; Gunnarsson R; Falk-Sorqvist E; Lonn P; Muggen AF; Yan X-J; Sander B; Enblad G; Smedby KE; Juliusson G; Belessi C; Rung J; Chiorazzi N; Strefford JC; Langerak AW; Pospisilova S; Davi F; Hellstrom M; Jernberg-Wiklund H; Ghia P; Soderberg O; Stamatopoulos K; Nilsson M; Rosenquist R
Article: MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY. 2015;22(6):633-639
Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study
Everhov AH; Nyberg T; Bergmark K; Citarella A; Radestad AF; Hirschberg AL; Smedby KE
Article: EUROPEAN JOURNAL OF CANCER. 2015;51(6):751-757
Distinct effects of anti-inflammatory and anti-thrombotic drugs on cancer characteristics at diagnosis
Pawitan Y; Yin L; Setiawan A; Auer G; Smedby KE; Czene K
Article: JOURNAL OF RHEUMATOLOGY. 2015;42(4):690-694
Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome
Knight A; Hjorton K; Sundstrom C; Hoglund M; Backlin C; Smedby KE; Askling J; Baecklund E
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2015;181(6):406-421
Associations of Non-Hodgkin Lymphoma (NHL) Risk With Autoimmune Conditions According to Putative NHL Loci
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; de Sanjose S; Cozen W; Alarcon GS; Martinez-Maza O; Brown EE; Bracci PM; Lightfoot T; Turner J; Hjalgrim H; Spinelli JJ; Zheng T; Morton LM; Birmann BM; Flowers CR; Paltiel O; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Foretova L; Staines A; Davis S; Severson R; Cerhan JR; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zhang Y; Skibola C; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Article: LEUKEMIA. 2015;29(2):329-336
Recurrent mutations refine prognosis in chronic lymphocytic leukemia
Baliakas P; Hadzidimitriou A; Sutton L-A; Rossi D; Minga E; Villamor N; Larrayoz M; Kminkova J; Agathangelidis A; Davis Z; Tausch E; Stalika E; Kantorova B; Mansouri L; Scarfo L; Cortese D; Navrkalova V; Rose-Zerilli MJJ; Smedby KE; Juliusson G; Anagnostopoulos A; Makris AM; Navarro A; Delgado J; Oscier D; Belessi C; Stilgenbauer S; Ghia P; Pospisilova S; Gaidano G; Campo E; Strefford JC; Stamatopoulos K; Rosenquist R
Article: BLOOD. 2015;125(5):856-859
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations
Baliakas P; Agathangelidis A; Hadzidimitriou A; Sutton L-A; Minga E; Tsanousa A; Scarfo L; Davis Z; Yan X-J; Shanafelt T; Plevova K; Sandberg Y; Vojdeman FJ; Boudjogra M; Tzenou T; Chatzouli M; Chu CC; Veronese S; Gardiner A; Mansouri L; Smedby KE; Pedersen LB; Moreno D; Van Lom K; Giudicelli V; Francova HS; Nguyen-Khac F; Panagiotidis P; Juliusson G; Angelis L; Anagnostopoulos A; Lefranc M-P; Facco M; Trentin L; Catherwood M; Montillo M; Geisler CH; Langerak AW; Pospisilova S; Chiorazzi N; Oscier D; Jelinek DF; Darzentas N; Belessi C; Davi F; Ghia P; Rosenquist R; Stamatopoulos K
Article: NATURE COMMUNICATIONS. 2015;6:5751
A genome-wide association study of marginal zone lymphoma shows association to the HLA region
Vijai J; Wang Z; Berndt SI; Skibola CF; Slager SL; de Sanjose S; Melbye M; Glimelius B; Bracci PM; Conde L; Birmann BM; Wang SS; Brooks-Wilson AR; Lan Q; de Bakker PIW; Vermeulen RCH; Portlock C; Ansell SM; Link BK; Riby J; North KE; Gu J; Hjalgrim H; Cozen W; Becker N; Teras LR; Spinelli JJ; Turner J; Zhang Y; Purdue MP; Giles GG; Kelly RS; Zeleniuch-Jacquotte A; Ennas MG; Monnereau A; Bertrand KA; Albanes D; Lightfoot T; Yeager M; Chung CC; Burdett L; Hutchinson A; Lawrence C; Montalvan R; Liang L; Huang J; Ma B; Villano DJ; Maria A; Corines M; Thomas T; Novak AJ; Dogan A; Liebow M; Thompson CA; Witzig TE; Habermann TM; Weiner GJ; Smith MT; Holly EA; Jackson RD; Tinker LF; Ye Y; Adami H-O; Smedby KE; De Roos AJ; Hartge P; Morton LM; Severson RK; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Mckay J; Staines A; Diver WR; Vajdic CM; Armstrong BK; Kricker A; Zheng T; Holford TR; Severi G; Vineis P; Ferri GM; Ricco R; Miligi L; Clavel J; Giovannucci E; Kraft P; Virtamo J; Smith A; Kane E; Roman E; Chiu BCH; Fraumeni JF; Wu X; Cerhan JR; Offit K; Chanock SJ; Rothman N; Nieters A
Article: TRANSLATIONAL ONCOLOGY. 2014;7(6):732-740
High Prevalence of Human Cytomegalovirus in Brain Metastases of Patients with Primary Breast and Colorectal Cancers
Taher C; Frisk G; Fuentes S; Religa P; Costa H; Assinger A; Vetvik KK; Bukholm IRK; Yaiw K-C; Smedby KE; Backlund M; Soderberg-Naucler C; Rahbar A
Article: NATURE GENETICS. 2014;46(11):1233-1238
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma
Cerhan JR; Berndt SI; Vijai J; Ghesquieres H; McKay J; Wang SS; Wang Z; Yeager M; Conde L; de Bakker PIW; Nieters A; Cox D; Burdett L; Monnereau A; Flowers CR; De Roos AJ; Brooks-Wilson AR; Lan Q; Severi G; Melbye M; Gu J; Jackson RD; Kane E; Teras LR; Purdue MP; Vajdic CM; Spinelli JJ; Giles GG; Albanes D; Kelly RS; Zucca M; Bertrand KA; Zeleniuch-Jacquotte A; Lawrence C; Hutchinson A; Zhi D; Habermann TM; Link BK; Novak AJ; Dogan A; Asmann YW; Liebow M; Thompson CA; Ansell SM; Witzig TE; Weiner GJ; Veron AS; Zelenika D; Tilly H; Haioun C; Molina TJ; Hjalgrim H; Glimelius B; Adami H-O; Bracci PM; Riby J; Smith MT; Holly EA; Cozen W; Hartge P; Morton LM; Severson RK; Tinker LF; North KE; Becker N; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; Lightfoot T; Crouch S; Smith A; Roman E; Diver WR; Offit K; Zelenetz A; Klein RJ; Villano DJ; Zheng T; Zhang Y; Holford TR; Kricker A; Turner J; Southey MC; Clavel J; Virtamo J; Weinstein S; Riboli E; Vineis P; Kaaks R; Trichopoulos D; Vermeulen RCH; Boeing H; Tjonneland A; Angelucci E; Di Lollo S; Rais M; Birmann BM; Laden F; Giovannucci E; Kraft P; Huang J; Ma B; Ye Y; Chiu BCH; Sampson J; Liang L; Park J-H; Chung CC; Weisenburger DD; Chatterjee N; Fraumeni JFJ; Slager SL; Wu X; de Sanjose S; Smedby KE; Salles G; Skibola CF; Rothman N; Chanock SJ
Article: PSYCHO-ONCOLOGY. 2014;23(11):1276-1282
Risk and predictors of attempted and completed suicide in patients with hematological malignancies
Mohammadi M; Moradi T; Bottai M; Reutfors J; Cao Y; Smedby KE
Article: LANCET HAEMATOLOGY. 2014;1(2):e74-e84
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
Baliakas P; Hadzidimitriou A; Sutton L-A; Minga E; Agathangelidis A; Nichelatti M; Tsanousa A; Scarfo L; Davis Z; Yan X-J; Shanafelt T; Plevova K; Sandberg Y; Vojdeman FJ; Boudjogra M; Tzenou T; Chatzouli M; Chu CC; Veronese S; Gardiner A; Mansouri L; Smedby KE; Pedersen LB; van Lom K; Giudicelli V; Francova HS; Nguyen-Khac F; Panagiotidis P; Juliusson G; Angelis L; Anagnostopoulos A; Lefranc M-P; Facco M; Trentin L; Catherwood M; Montillo M; Geisler CH; Langerak AW; Pospisilova S; Chiorazzi N; Oscier D; Jelinek DF; Darzentas N; Belessi C; Davi F; Rosenquist R; Ghia P; Stamatopoulos K
Article: BMC MEDICAL GENETICS. 2014;15:113
A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival
Baecklund F; Foo J-N; Bracci P; Darabi H; Karlsson R; Hjalgrim H; Rosenquist R; Adami H-O; Glimelius B; Melbye M; Conde L; Liu J; Humphreys K; Skibola CF; Smedby KE
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2014;95(4):462-471
Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region
Skibola CF; Berndt SI; Vijai J; Conde L; Wang Z; Yeager M; de Bakker PIW; Birmann BM; Vajdic CM; Foo J-N; Bracci PM; Vermeulen RCH; Slager SL; de Sanjose S; Wang SS; Linet MS; Salles G; Lan Q; Severi G; Hjalgrim H; Lightfoot T; Melbye M; Gu J; Ghesquieres H; Link BK; Morton LM; Holly EA; Smith A; Tinker LF; Teras LR; Kricker A; Becker N; Purdue MP; Spinelli JJ; Zhang Y; Giles GG; Vineis P; Monnereau A; Bertrand KA; Albanes D; Zeleniuch-Jacquotte A; Gabbas A; Chung CC; Burdett L; Hutchinson A; Lawrence C; Montalvan R; Liang L; Huang J; Ma B; Liu J; Adami H-O; Glimelius B; Ye Y; Nowakowski GS; Dogan A; Thompson CA; Habermann TM; Novak AJ; Liebow M; Witzig TE; Weiner GJ; Schenk M; Hartge P; De Roos AJ; Cozen W; Zhi D; Akers NK; Riby J; Smith MT; Lacher M; Villano DJ; Maria A; Roman E; Kane E; Jackson RD; North KE; Diver WR; Turner J; Armstrong BK; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; McKay J; Brooks-Wilson AR; Zheng T; Holford TR; Chamosa S; Kaaks R; Kelly RS; Ohlsson B; Travis RC; Weiderpass E; Clave J; Giovannucci E; Kraft P; Virtamo J; Mazza P; Cocco P; Ennas MG; Chiu BCH; Fraumeni JRJ; Nieters A; Offit K; Wu X; Cerhan JR; Smedby KE; Chanock SJ; Rothman N
Article: ANNALS OF SURGICAL ONCOLOGY. 2014;21(11):3386-3394
Sentinel Node Location in Trunk and Extremity Melanomas: Uncommon or Multiple Lymph Drainage Does Not Affect Survival
Gordon D; Smedby KE; Schultz I; Olsson H; Ingvar C; Hansson J; Gillgren P
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2014;93(9):949-953
Anti-Mullerian hormone in premenopausal women following treatment of uterine cervical cancer
Everhov AH; Bergmark K; Smedby KE; Hirschberg AL; Radestad AF
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. MONOGRAPHS. 2014;2014(48):130-144
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Morton LM; Slager SL; Cerhan JR; Wang SS; Vajdic CM; Skibola CF; Bracci PM; de Sanjosé S; Smedby KE; Chiu BCH; Zhang Y; Mbulaiteye SM; Monnereau A; Turner JJ; Clavel J; Adami H-O; Chang ET; Glimelius B; Hjalgrim H; Melbye M; Crosignani P; di Lollo S; Miligi L; Nanni O; Ramazzotti V; Rodella S; Costantini AS; Stagnaro E; Tumino R; Vindigni C; Vineis P; Becker N; Benavente Y; Boffetta P; Brennan P; Cocco P; Foretova L; Maynadié M; Nieters A; Staines A; Colt JS; Cozen W; Davis S; de Roos AJ; Hartge P; Rothman N; Severson RK; Holly EA; Call TG; Feldman AL; Habermann TM; Liebow M; Blair A; Cantor KP; Kane EV; Lightfoot T; Roman E; Smith A; Brooks-Wilson A; Connors JM; Gascoyne RD; Spinelli JJ; Armstrong BK; Kricker A; Holford TR; Lan Q; Zheng T; Orsi L; Dal Maso L; Franceschi S; La Vecchia C; Negri E; Serraino D; Bernstein L; Levine A; Friedberg JW; Kelly JL; Berndt SI; Birmann BM; Clarke CA; Flowers CR; Foran JM; Kadin ME; Paltiel O; Weisenburger DD; Linet MS; Sampson JN
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. MONOGRAPHS. 2014;2014(48):76-86
Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Smedby KE; Sampson JN; Turner JJ; Slager SL; Maynadié M; Roman E; Habermann TM; Flowers CR; Berndt SI; Bracci PM; Hjalgrim H; Weisenburger DD; Morton LM
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. MONOGRAPHS. 2014;2014(48):52-65
Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Bracci PM; Benavente Y; Turner JJ; Paltiel O; Slager SL; Vajdic CM; Norman AD; Cerhan JR; Chiu BCH; Becker N; Cocco P; Dogan A; Nieters A; Holly EA; Kane EV; Smedby KE; Maynadié M; Spinelli JJ; Roman E; Glimelius B; Wang SS; Sampson JN; Morton LM; de Sanjosé S
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. MONOGRAPHS. 2014;2014(48):1-14
Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
Morton LM; Sampson JN; Cerhan JR; Turner JJ; Vajdic CM; Wang SS; Smedby KE; de Sanjosé S; Monnereau A; Benavente Y; Bracci PM; Chiu BCH; Skibola CF; Zhang Y; Mbulaiteye SM; Spriggs M; Robinson D; Norman AD; Kane EV; Spinelli JJ; Kelly JL; La Vecchia C; Dal Maso L; Maynadié M; Kadin ME; Cocco P; Costantini AS; Clarke CA; Roman E; Miligi L; Colt JS; Berndt SI; Mannetje A; de Roos AJ; Kricker A; Nieters A; Franceschi S; Melbye M; Boffetta P; Clavel J; Linet MS; Weisenburger DD; Slager SL
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2014;40(3):280-287
Mortality after total colectomy in 3084 patients with inflammatory bowel disease: a population-based cohort study
Nordenvall C; Ekbom A; Bottai M; Smedby KE; Nilsson PJ
Article: NATURE COMMUNICATIONS. 2014;5:3856
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus
Cozen W; Timofeeva MN; Li D; Diepstra A; Hazelett D; Delahaye-Sourdeix M; Edlund CK; Franke L; Rostgaard K; Van Den Berg DJ; Cortessis VK; Smedby KE; Glaser SL; Westra H-J; Robison LL; Mack TM; Ghesquieres H; Hwang AE; Nieters A; de Sanjose S; Lightfoot T; Becker N; Maynadie M; Foretova L; Roman E; Benavente Y; Rand KA; Nathwani BN; Glimelius B; Staines A; Boffetta P; Link BK; Kiemeney L; Ansell SM; Bhatia S; Strong LC; Galan P; Vatten L; Habermann TM; Duell EJ; Lake A; Veenstra RN; Visser L; Liu Y; Urayama KY; Montgomery D; Gaborieau V; Weiss LM; Byrnes G; Lathrop M; Cocco P; Best T; Skol AD; Adami H-O; Melbye M; Cerhan JR; Gallagher A; Taylor GM; Slager SL; Brennan P; Coetzee GA; Conti DV; Onel K; Jarrett RF; Hjalgrim H; van den Berg A; Mckay JD
Article: BMC CANCER. 2014;14:391
Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden
Holmes MD; Olsson H; Pawitan Y; Holm J; Lundholm C; Andersson TM-L; Adami H-O; Askling J; Smedby KE
Article: LEUKEMIA RESEARCH. 2014;38(6):682-690
Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays
Pauly F; Smedby KE; Jerkeman M; Hjalgrim H; Ohlsson M; Rosenquist R; Borrebaeck CAK; Wingren C
Article: ARTHRITIS & RHEUMATOLOGY. 2014;66(5):1282-1290
Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden
Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2014;39(1):57-68
Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study
Busch K; Ludvigsson JF; Ekstrom-Smedby K; Ekbom A; Askling J; Neovius M
Article: NATURE GENETICS. 2014;46(1):56-60
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia
Speedy HE; Di Bernardo MC; Sava GP; Dyer MJS; Holroyd A; Wang Y; Sunter NJ; Mansouri L; Juliusson G; Smedby KE; Roos G; Jayne S; Majid A; Dearden C; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Catovsky D; Allan JM; Houlston RS
Article: BLOOD. 2013;122(20):3492-3499
Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis
Monnereau A; Glaser SL; Schupp CW; Smedby KE; de Sanjosé S; Kane E; Melbye M; Forétova L; Maynadié M; Staines A; Becker N; Nieters A; Brennan P; Boffetta P; Cocco P; Glimelius I; Clavel J; Hjalgrim H; Chang ET
Article: BRITISH JOURNAL OF CANCER. 2013;109(7):1921-1925
Low-dose aspirin use and cancer characteristics: a population-based cohort study
Jonsson F; Yin L; Lundholm C; Smedby KE; Czene K; Pawitan Y
Article: TRANSPLANTATION. 2013;96(3):297-305
Overall and Cause-Specific Mortality in Transplant Recipients with a Pretransplantation Cancer History
Brattstrom C; Granath F; Edgren G; Smedby KE; Wilczek HE
Article: ANNALS OF INTERNAL MEDICINE. 2013;159(3):169-175
Mucosal Healing and Risk for Lymphoproliferative Malignancy in Celiac Disease A Population-Based Cohort Study
Lebwohl B; Granath F; Ekbom A; Smedby KE; Murray JA; Neugut AI; Green PHR; Ludvigsson JF
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2013;88(8):647-651
Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients
Mansouri L; Grabowski P; Degerman S; Svenson U; Gunnarsson R; Cahill N; Smedby KE; Geisler C; Juliusson G; Roos G; Rosenquist R
Article: NATURE GENETICS. 2013;45(8):868-876
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
Berndt SI; Skibola CF; Joseph V; Camp NJ; Nieters A; Wang Z; Cozen W; Monnereau A; Wang SS; Kelly RS; Lan Q; Teras LR; Chatterjee N; Chung CC; Yeager M; Brooks-Wilson AR; Hartge P; Purdue MP; Birmann BM; Armstrong BK; Cocco P; Zhang Y; Severi G; Zeleniuch-Jacquotte A; Lawrence C; Burdette L; Yuenger J; Hutchinson A; Jacobs KB; Call TG; Shanafelt TD; Novak AJ; Kay NE; Liebow M; Wang AH; Smedby KE; Adami H-O; Melbye M; Glimelius B; Chang ET; Glenn M; Curtin K; Cannon-Albright LA; Jones B; Diver WR; Link BK; Weiner GJ; Conde L; Bracci PM; Riby J; Holly EA; Smith MT; Jackson RD; Tinker LF; Benavente Y; Becker N; Boffetta P; Brennan P; Foretova L; Maynadie M; McKay J; Staines A; Rabe KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Lanasa MC; Spector LG; Leis JF; Cunningham JM; Weinberg JB; Morrison VA; Caporaso NE; Norman AD; Linet MS; De Roos AJ; Morton LM; Severson RK; Riboli E; Vineis P; Kaaks R; Trichopoulos D; Masala G; Weiderpass E; Chirlaque M-D; Vermeulen RCH; Travis RC; Giles GG; Albanes D; Virtamo J; Weinstein S; Clavel J; Zheng T; Holford TR; Offit K; Zelenetz A; Klein RJ; Spinelli JJ; Bertrand KA; Laden F; Giovannucci E; Kraft P; Kricker A; Turner J; Vajdic CM; Ennas MG; Ferri GM; Miligi L; Liang L; Sampson J; Crouch S; Park J-H; North KE; Cox A; Snowden JA; Wright J; Carracedo A; Lopez-Otin C; Bea S; Salaverria I; Martin-Garcia D; Campo E; Fraumeni JFJ; de Sanjose S; Hjalgrim H; Cerhan JR; Chanock SJ; Rothman N; Slager SL
Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2013;93(1):167-172
Coding Variants at Hexa-allelic Amino Acid 13 of HLA-DRB1 Explain Independent SNP Associations with Follicular Lymphoma Risk
Foo JN; Smedby KE; Akers NK; Berglund M; Irwan ID; Jia X; Li Y; Conde L; Darabi H; Bracci PM; Melbye M; Adami H-O; Glimelius B; Khor CC; Hjalgrim H; Padyukov L; Humphreys K; Enblad G; Skibola CF; de Bakker PIW; Liu J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2013;162(2):221-228
rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
Sava GP; Speedy HE; Di Bernardo MC; Deaglio S; Karabon L; Frydecka I; Woszczyk D; Rossi D; Gaidano G; Mansouri L; Smedby KE; Juliusson G; Rosenquist R; Catovsky D; Houlston RS
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(11):2659-2666
Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes
Simard JF; Baecklund F; Chang ET; Baecklund E; Hjalgrim H; Adami H-O; Glimelius B; Smedby KE
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(6):1429-1438
Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-A Swedish population-based study
Krynitz B; Edgren G; Lindelof B; Baecklund E; Brattstrom C; Wilczek H; Smedby KE
Article: GASTROENTEROLOGY. 2013;144(3):536-543
Patients With Ulcerative Colitis Miss More Days of Work Than the General Population, Even Following Colectomy
Neovius M; Arkema EV; Blomqvist P; Ekbom A; Smedby KE
Article: LAKARTIDNINGEN. 2013;110(3):81
["Tools for clinical research"--a new series of articles in Läkartidningen].
Smedby KE; Lagerros YT
Article: PLOS ONE. 2013;8(9):e74619
Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma.
Bretherick KL; Schuetz JM; Morton LM; Purdue MP; Conde L; Gallagher RP; Connors JM; Gascoyne RD; Berry BR; Armstrong B; Kricker A; Vajdic CM; Grulich A; Hjalgrim H; Smedby KE; Skibola CF; Rothman N; Spinelli JJ; Brooks-Wilson AR
Article: CANCER CAUSES & CONTROL. 2013;24(1):125-134
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium
Gibson TM; Smedby KE; Skibola CF; Hein DW; Slager SL; de Sanjose S; Vajdic CM; Zhang Y; Chiu BC-H; Wang SS; Hjalgrim H; Nieters A; Bracci PM; Kricker A; Zheng T; Kolar C; Cerhan JR; Darabi H; Becker N; Conde L; Holford TR; Weisenburger DD; De Roos AJ; Butterbach K; Riby J; Cozen W; Benavente Y; Palmers C; Holly EA; Sampson JN; Rothman N; Armstrong BK; Morton LM
Article: LEUKEMIA. 2013;27(1):150-158
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
Cahill N; Bergh A-C; Kanduri M; Goransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Smedby KE; Juliusson G; Sundstrom C; Rosen A; Rosenquist R
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;131(10):2342-2348
Self-reported history of infections and the risk of non-Hodgkin lymphoma: An InterLymph pooled analysis
Becker N; Falster MO; Vajdic CM; de Sanjose S; Martinez-Maza O; Bracci PM; Melbye M; Smedby KE; Engels EA; Turner J; Vineis P; Costantini AS; Holly EA; Spinelli JJ; La Vecchia C; Zheng T; Chiu BC-H; Montella M; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Cozen W; Grulich AE; Newton R
Article: ACTA DERMATO-VENEREOLOGICA. 2012;92(6):609-614
No Association between Infections, HLA Type and Other Transplant-related Factors and Risk of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients
Ingvar A; Smedby KE; Lindelof B; Fernberg P; Bellocco R; Tufveson G; Hoglund P; Adami J
Article: BMC GENOMICS. 2012;13:516
A meta-analysis of genome-wide association studies of follicular lymphoma
Skibola CF; Conde L; Foo J-N; Riby J; Humphreys K; Sille FCM; Darabi H; Sanchez S; Hjalgrim H; Liu J; Bracci PM; Smedby KE
Article: HISTOPATHOLOGY. 2012;61(1):26-32
Tissue microarray and digital image analysis: a methodological study with special reference to the microenvironment in Hodgkin lymphoma
Glimelius I; Qvarnstrom F; Simonsson M; Ekwall A; Smedby KE; Molin D; Amini R-M
Article: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2012;12(3):201-206
IGHV3-21 Gene Frequency in a Swedish Cohort of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
Cahill N; Sutton L-A; Jansson M; Murray F; Mansouri L; Gunnarsson R; Ryan F; Smedby KE; Geisler C; Juliusson G; Rosenquist R
Article: BRITISH JOURNAL OF CANCER. 2012;106(11):1850-1853
Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden
Frisk G; Svensson T; Backlund LM; Lidbrink E; Blomqvist P; Smedby KE
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2012;104(3):240-253
Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein-Barr Virus Status-Defined Subgroups
Urayama KY; Jarrett RF; Hjalgrim H; Diepstra A; Kamatani Y; Chabrier A; Gaborieau V; Boland A; Nieters A; Becker N; Foretova L; Benavente Y; Maynadie M; Staines A; Shield L; Lake A; Montgomery D; Taylor M; Smedby KE; Amini R-M; Adami H-O; Glimelius B; Feenstra B; Nolte IM; Visser L; van Imhoff GW; Lightfoot T; Cocco P; Kiemeney L; Vermeulen SH; Holcatova I; Vatten L; Macfarlane GJ; Thomson P; Conway DI; Benhamou S; Agudo A; Healy CM; Overvad K; Tjonneland A; Melin B; Canzian F; Khaw K-T; Travis RC; Peeters PHM; Gonzalez CA; Quiros JR; Sanchez M-J; Maria Huerta J; Ardanaz E; Dorronsoro M; Clavel-Chapelon F; Bueno-de-Mesquita HB; Riboli E; Roman E; Boffetta P; de Sanjose S; Zelenika D; Melbye M; van den Berg A; Lathrop M; Brennan P; McKay JD
Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2011;11(11):2472-2482
Time Trends in Risk and Risk Determinants of Non-Hodgkin Lymphoma in Solid Organ Transplant Recipients
Fernberg P; Edgren G; Adami J; Ingvar A; Bellocco R; Tufveson G; Hoglund P; Kinch A; Simard JF; Baecklund E; Lindelof B; Pawitan Y; Smedby KE
Article: DIGESTIVE AND LIVER DISEASE. 2011;43(11):862-868
Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype
Olen O; Askling J; Ludvigsson JF; Hildebrand H; Ekbom A; Smedby KE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(3):208-216
Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's Lymphoma - a population-based study
Glimelius I; Rubin J; Rostgaard K; Amini R-M; Simonsson M; Sorensen KM; Smedby KE; Venge P; Hjalgrim H; Molin D; Enblad G
Article: HAEMATOLOGICA. 2011;96(8):1161-1169
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
Gunnarsson R; Mansouri L; Isaksson A; Goransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
Article: HAEMATOLOGICA. 2011;96(8):1153-1160
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia
Kaderi MA; Kanduri M; Buhl AM; Sevov M; Cahill N; Gunnarsson R; Jansson M; Smedby KE; Hjalgrim H; Jurlander J; Juliusson G; Mansouri L; Rosenquist R
Article: PLOS GENETICS. 2011;7(4):e1001378
GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma
Smedby KE; Foo JN; Skibola CF; Darabi H; Conde L; Hjalgrim H; Kumar V; Chang ET; Rothman N; Cerhan JR; Brooks-Wilson AR; Rehnberg E; Irwan ID; Ryder LP; Brown PN; Bracci PM; Agana L; Riby J; Cozen W; Davis S; Hartge P; Morton LM; Severson RK; Wang SS; Slager SL; Fredericksen ZS; Novak AJ; Kay NE; Habermann TM; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Leach S; Spinelli JJ; Smith MT; Chanock SJ; Padyukov L; Alfredsson L; Klareskog L; Glimelius B; Melbye M; Liu ET; Adami H-O; Humphreys K; Liu J
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2011;103(5):436-444
Risk of Lymphoproliferative Malignancy in Relation to Small Intestinal Histopathology Among Patients With Celiac Disease
Elfstrom P; Granath F; Smedby KE; Montgomery SM; Askling J; Ekbom A; Ludvigsson JF
Article: LEUKEMIA RESEARCH. 2011;35(2):272-274
TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
Zainuddin N; Murray F; Kanduri M; Gunnarsson R; Smedby KE; Enblad G; Jurlander J; Juliusson G; Rosenquist R
Article: AMERICAN JOURNAL OF TRANSPLANTATION. 2011;11(1):146-151
Pediatric Organ Transplantation and Risk of Premalignant and Malignant Tumors in Sweden
Simard JF; Baecklund E; Kinch A; Brattstrom C; Ingvar A; Molin D; Adami J; Fernberge P; Wilczek H; Ekbom A; Smedby KE
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2011;173(1):48-54
Vitamin D Receptor Genotypes, Ultraviolet Radiation Exposure, and Risk of Non-Hodgkin Lymphoma
Smedby KE; Eloranta S; Duvefelt K; Melbye M; Humphreys K; Hjalgrim H; Chang ET
Article: NATURE GENETICS. 2010;42(12):1126-1130
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)
Enciso-Mora V; Broderick P; Ma Y; Jarrett RF; Hjalgrim H; Hemminki K; van den Berg A; Olver B; Lloyd A; Dobbins SE; Lightfoot T; van Leeuwen FE; Foersti A; Diepstra A; Broeks A; Vijayakrishnan J; Shield L; Lake A; Montgomery D; Roman E; Engert A; von Strandmann EP; Reiners KS; Nolte IM; Smedby KE; Adami H-O; Russell NS; Glimelius B; Hamilton-Dutoit S; de Bruin M; Ryder LP; Molin D; Sorensen KM; Chang ET; Taylor M; Cooke R; Hofstra R; Westers H; van Wezel T; van Eijk R; Ashworth A; Rostgaard K; Melbye M; Swerdlow AJ; Houlston RS
Article: HAEMATOLOGICA. 2010;95(12):2072-2079
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
Marincevic M; Mansouri M; Kanduri M; Isaksson A; Goransson H; Smedby KE; Jurlander J; Juliusson G; Davi F; Stamatopoulos K; Rosenquist R
Article: NATURE GENETICS. 2010;42(8):661-664
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32
Conde L; Halperin E; Akers NK; Brown KM; Smedby KE; Rothman N; Nieters A; Slager SL; Brooks-Wilson A; Agana L; Riby J; Liu J; Adami H-O; Darabi H; Hjalgrim H; Low H-Q; Humphreys K; Melbye M; Chang ET; Glimelius B; Cozen W; Davis S; Hartge P; Morton LM; Schenk M; Wang SS; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Becker N; Benavente Y; Boffetta P; Brennan P; Butterbach K; Cocco P; Foretova L; Maynadie M; de Sanjose S; Staines A; Spinelli JJ; Achenbach SJ; Call TG; Camp NJ; Glenn M; Caporaso NE; Cerhan JR; Cunningham JM; Goldin LR; Hanson CA; Kay NE; Lanasa MC; Leis JF; Marti GE; Rabe KG; Rassenti LZ; Spector LG; Strom SS; Vachon CM; Weinberg JB; Holly EA; Chanock S; Smith MT; Bracci PM; Skibola CF
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2010;25(8):2764-2771
Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma
Ingvar A; Smedby KE; Lindelof B; Fernberg P; Bellocco R; Tufveson G; Hoglund P; Adami J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;150(4):473-479
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk
Crowther-Swanepoel D; Mansouri M; Enjuanes A; Vega A; Smedby KE; Ruiz-Ponte C; Jurlander J; Juliusson G; Montserrat E; Catovsky D; Campo E; Carracedo A; Rosenquist R; Houlston RS
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2010;19(6):1569-1576
Pigmentary Characteristics, UV Radiation Exposure, and Risk of Non-Hodgkin Lymphoma: a Prospective Study among Scandinavian Women
Veierod MB; Smedby KE; Lund E; Adami H-O; Weiderpass E
Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(5):1252-1258
Do Rheumatoid Arthritis and Lymphoma Share Risk Factors? A Comparison of Lymphoma and Cancer Risks Before and After Diagnosis of Rheumatoid Arthritis
Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
Article: CANCER CAUSES & CONTROL. 2010;21(5):759-769
Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma
Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sorensen KM; Porwit A; Humphreys K; Melbye M; Smedby KE
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(14):6400-6405
HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
Hjalgrim H; Rostgaard K; Johnson PCD; Lake A; Shield L; Little A-M; Ekstrom-Smedby K; Adami H-O; Glimelius B; Hamilton-Dutoit S; Kane E; Taylor GM; McConnachie A; Ryder LP; Sundstrom C; Andersen PS; Chang ET; Alexander FE; Melbye M; Jarrett RF
Article: NATURE GENETICS. 2010;42(2):132-136
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
Crowther-Swanepoel D; Broderick P; Di Bernardo MC; Dobbins SE; Torres M; Mansouri M; Ruiz-Ponte C; Enjuanes A; Rosenquist R; Carracedo A; Jurlander J; Campo E; Juliusson G; Montserrat E; Smedby KE; Dyer MJS; Matutes E; Dearden C; Sunter NJ; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Parker A; Oscier D; Allan JM; Catovsky D; Houlston RS
Article: BRITISH JOURNAL OF CANCER. 2009;101(11):1919-1924
Brain metastases admissions in Sweden between 1987 and 2006
Smedby KE; Brandt L; Backlund ML; Blomqvist P
Journal article: BLOOD. 2009;114(22):269
Risk of EBV-Positive Hodgkin Lymphoma Varies Over 30-Fold by HLA Class I Genotype and History of Infectious Mononucleosis.
Jarrett R; Johnson PC; Rostgaard K; Lake A; Shield L; Little A-M; Ekstrom-Smedby K; Adami HO; Glimelius B; Dutoit SH; Kane E; Taylor GM; McConnachie A; Ryder LP; Sundstrom C; Andersen PS; Chang ET; Alexander F; Melbye M; Hjalgrim H
Article: CANCER RESEARCH. 2009;69(16):6482-6489
Atopic Disease and Risk of Non-Hodgkin Lymphoma: An InterLymph Pooled Analysis
Vajdic CM; Falster MO; de Sanjose S; Martinez-Maza O; Becker N; Bracci PM; Melbye M; Smedby KE; Engels EA; Turner J; Vineis P; Costantini AS; Holly EA; Kane E; Spinelli JJ; La Vecchia C; Zheng T; Chiu BC-H; Dal Maso L; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Cozen W; Grulich AE
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(11):2616-2620
Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma
Biggar RJ; Christiansen M; Rostgaard K; Smedby KE; Adami H-O; Glimelius B; Hjalgrim H; Melbye M
Article: CLINICAL CANCER RESEARCH. 2008;14(21):6974-6978
Serum YKL-40 and Interleukin 6 Levels in Hodgkin Lymphoma
Biggar RJ; Johansen JS; Smedby KE; Rostgaard K; Chang ET; Adami H-O; Glimelius B; Molin D; Hamilton-Dutoit S; Melbye M; Hjalgrim H
Article: GENES CHROMOSOMES & CANCER. 2008;47(8):697-711
Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia -: A comparative study of four differently designed, high resolution Microarray platforms
Gunnarsson R; Staaf J; Jansson M; Ottesen AM; Goransson H; Liljedahl U; Ralfkiaer U; Mansouri M; Buhl AM; Smedby KE; Hialgrim H; Syvanen A-C; Borg A; Isaksson A; Jurlander J; Juliusson G; Rosenquist R
Article: BLOOD. 2008;111(12):5524-5529
Borrelia infection and risk of non-Hodgkin lymphoma
Schollkopf C; Melbye M; Munksgaard L; Smedby KE; Rostgaard K; Glimelius B; Chang ET; Roos G; Hansen M; Adami H-O; Hjalgrim H
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;122(9):2062-2070
Non-Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph consortium
Willett EV; Morton LM; Hartge P; Becker N; Bernstein L; Boffetta P; Bracci P; Cerhan J; Chiu BC-H; Cocco P; Dal Maso L; Davis S; De Sanjose S; Smedby KE; Ennas MG; Foretova L; Holiy EA; La Vecchia C; Matsuo K; Maynadie M; Melbye M; Negri E; Nieters A; Severson R; Slager SL; Spinelli JJ; Staines A; Talamini R; Vornanen M; Weisenburger DD; Roman E
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;122(8):1885-1890
Hepatitis C infection and risk of malignant lymphoma
Schoellkopf C; Smedby KE; Hjalgrim H; Rostgaard K; Panum I; Vinner L; Chang ET; Glimelius B; Porwit A; Sundstroem C; Hansen M; Adami H-O; Melbye M
Article: BLOOD. 2008;111(8):4029-4038
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes:: a pooled analysis within the InterLymph consortium
Smedby KE; Vajdic CM; Falster M; Engels EA; Martinez-Maza O; Turner J; Hjalgrim H; Vineis P; Costantini AS; Bracci PM; Holly EA; Willett E; Spinelli JJ; La Vecchia C; Zheng T; Becker N; De Sanjose S; Chiu BC-H; Dal Maso L; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Davis S; Severson R; Cerhan JR; Breen EC; Birmann B; Grulich AE; Cozen W
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;122(1):144-154
Personal sun exposure and risk of non Hodgkin lymphoma:: A pooled analysis from the Interlymph Consortium
Kricker A; Armstrong BK; Hughes AM; Goumas C; Smedby KE; Zheng T; Spinelli JJ; De Sanjose S; Hartge P; Melbye M; Willett EV; Becker N; Chiu BCH; Cerhan JR; Maynadie M; Staines A; Cocco P; Boffeta P
Article: CANCER RESEARCH. 2007;67(22):11074-11082
Childhood social environment and risk of non-hodgkin lymphoma in adults
Smedby KE; Hjalgrim H; Chang ET; Rostgaard K; Glimelius B; Adami H-O; Melbye M
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2007;16(8):1561-1566
Cigarette smoking and risk of Hodgkin lymphoma:: A population-based case-control study
Hjalgrim H; Ekstrom-Smedby K; Rostgaard K; Amini R-M; Molin D; Hamilton-Dutoit S; Schollkopf C; Chang ET; Ralfkiaer E; Adami H-O; Glimelius B; Melbye M
Article: CANCER RESEARCH. 2007;67(5):2382-2388
Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma
Hjalgrim H; Smedby KE; Rostgaard K; Molin D; Hamilton-Dutoit S; Chang ET; Ralfkiaer E; Sundstrom C; Adami H-O; Glimelius B; Melbye M
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2007;99(2):158-166
Atopy and risk of non-Hodgkin lymphoma
Melbye M; Smedby KE; Lehtinen T; Rostgaard K; Glimelius B; Munksgaard L; Schollkopf C; Sundstrom C; Chang ET; Koskela P; Adami H-O; Hjalgrim H
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2006;164(12):1222-1232
Nutrient intake and risk of non-Hodgkin's lymphoma
Chang ET; Balter KM; Torrang A; Smedby KE; Melbye M; Sundstrom C; Glimelius B; Adami H-O
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006;15(2):258-265
Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma
Smedby KE; Lindgren CM; Hjalgrim H; Humphreys K; Schöllkopf C; Chang ET; Roos G; Ryder LP; Falk KI; Palmgren J; Kere J; Melbye M; Glimelius B; Adami HO
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2006;98(1):61-68
Reliability of self-reported family history of cancer in a large case-control study of lymphoma
Chang ET; Smedby KE; Hjalgrim H; Glimelius B; Adami HO
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2006;98(1):51-60
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype
Smedby KE; Hjalgrim H; Askling J; T Chang E; Gregersen H; Porwit-MacDonald A; Sundström C; Åkerman M; Melbye M; Glimelius B; Adami HO
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2005;162(10):965-974
Medication use and risk of non-Hodgkin's lymphoma
Chang ET; Smedby KE; Hjalgrim H; Schöllkopf C; Porwit-MacDonald A; Sundström C; Tani E; d'Amore F; Melbye M; Adami HO; Glimelius B
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2005;97(19):1466-1474
Family history of hematopoietic malignancy and risk of lymphoma
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2005;14(7):1791-1796
Cigarette smoking and risk of non-hodgkin's lymphoma -: A population-based case-control study
Schöllkopf C; Smedby KE; Hjalgrim H; Rostgaard K; Gadeberg O; Roos G; Porwit-MacDonald A; Glimelius B; Adami HO; Melbye M
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2005;97(3):210-218
Body mass index and risk of malignant lymphoma in Scandinavian men and women
Chang ET; Hjalgrim H; Smedby KE; Åkerman M; Tani E; Johnsen HE; Glimelius B; Adami HO; Melbye M
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2005;97(3):199-209
Ultraviolet radiation exposure and risk of malignant lymphomas
Smedby KE; Hjalgrim H; Melbye M; Torrång A; Rostgaard K; Munksgaard L; Adami J; Hansen M; Porwit-MacDonald A; Jensen BA; Roos G; Pedersen BB; Sundström C; Glimelius B; Adami HO
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2005;14(2):512-520
Dietary factors and risk of non-Hodgkin lymphoma in men and women
Chang ET; Smedby KE; Zhang SM; Hjalgrim H; Melbye M; Öst Å; Glimelius B; Wolk A; Adami HO
Article: GUT. 2005;54(1):54-59
Malignant lymphomas in coeliac disease:: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma
Smedby KE; Åkerman M; Hildebrand H; Glimelius B; Ekbom A; Askling J
Article: CANCER CAUSES & CONTROL. 2004;15(10):1067-1076
Alcohol intake and risk of non-Hodgkin lymphoma in men and women
Chang ET; Smedby KE; Zhang SM; Hjalgrim H; Melbye M; Öst A; Wolk A; Adami HO; Glimelius B
Article: BRITISH JOURNAL OF CANCER. 2003;89(7):1221-1227
Cancer risk following organ transplantation:: a nationwide cohort study in Sweden
Adami J; Gäbel H; Lindelöf B; Ekström K; Rydh B; Glimelius B; Ekbom A; Adami HO; Granath F
Article: ARTHRITIS & RHEUMATOLOGY. 2003;48(4):963-970
Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives
Ekström K; Hjalgrim H; Brandt L; Baecklund E; Klareskog L; Ekbom A; Askling J
Article: GASTROENTEROLOGY. 2002;123(5):1428-1435
Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis
Askling J; Linet M; Gridley G; Halstensen TS; Ekström K; Ekbom A
Article: CANCER CAUSES & CONTROL. 2002;13(1):47-53
Childbearing and the risk of leukemia in Sweden
Ekström K; Wuu J; Hsieh CC; Glimelius B; Lambe M
Article: ONCOLOGY REPORTS. 1998;5(4):931-934
Single-dose etoposide in advanced pancreatic and biliary cancer, a phase II study.
Ekstrom K; Hoffman K; Linne T; Eriksson B; Glimelius B
Article: ANNALS OF ONCOLOGY. 1997;8(2):163-168
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.
Glimelius B; Ekström K; Hoffman K; Graf W; Sjödén PO; Haglund U; Svensson C; Enander LK; Linné T; Sellström H; Heuman R
Article: DISEASES OF THE COLON & RECTUM. 1996;39(7):744-749
A pilot study of factors influencing bowel function after colorectal anastomosis.
Graf W; Ekström K; Glimelius B; Påhlman L
Show more

All other publications

Review: JOURNAL OF INTERNAL MEDICINE. 2023;294(4):413-436
Novel precision medicine approaches and treatment strategies in hematological malignancies
Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Ostling P; Cavelier L; Fioretos T; Smedby KE
Corrigendum: LEUKEMIA. 2023;37(10):2142
Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.
Berndt SI; Vijai J; Benavente Y; Camp NJ; Nieters A; Wang Z; Smedby KE; Kleinstern G; Hjalgrim H; Besson C; Skibola CF; Morton LM; Brooks-Wilson AR; Teras LR; Breeze C; Arias J; Adami H-O; Albanes D; Anderson KC; Ansell SM; Bassig B; Becker N; Bhatti P; Birmann BM; Boffetta P; Bracci PM; Brennan P; Brown EE; Burdett L; Cannon-Albright LA; Chang ET; Chiu BCH; Chung CC; Clavel J; Cocco P; Colditz G; Conde L; Conti DV; Cox DG; Curtin K; Casabonne D; De Vivo I; Diepstra A; Diver WR; Dogan A; Edlund CK; Foretova L; Fraumeni JF; Gabbas A; Ghesquières H; Giles GG; Glaser S; Glenn M; Glimelius B; Gu J; Habermann TM; Haiman CA; Haioun C; Hofmann JN; Holford TR; Holly EA; Hutchinson A; Izhar A; Jackson RD; Jarrett RF; Kaaks R; Kane E; Kolonel LN; Kong Y; Kraft P; Kricker A; Lake A; Lan Q; Lawrence C; Li D; Liebow M; Link BK; Magnani C; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Monnereau A; Montalvan R; North KE; Novak AJ; Onel K; Purdue MP; Rand KA; Riboli E; Riby J; Roman E; Salles G; Sborov DW; Severson RK; Shanafelt TD; Smith MT; Smith A; Song KW; Song L; Southey MC; Spinelli JJ; Staines A; Stephens D; Sutherland HJ; Tkachuk K; Thompson CA; Tilly H; Tinker LF; Travis RC; Turner J; Vachon CM; Vajdic CM; Van Den Berg A; Van Den Berg DJ; Vermeulen RCH; Vineis P; Wang SS; Weiderpass E; Weiner GJ; Weinstein S; Doo NW; Ye Y; Yeager M; Yu K; Zeleniuch-Jacquotte A; Zhang Y; Zheng T; Ziv E; Sampson J; Chatterjee N; Offit K; Cozen W; Wu X; Cerhan JR; Chanock SJ; Slager SL; Rothman N
Letter: ACTA ONCOLOGICA. 2023;62(6):560-564
The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results
Smedby KE; Waesterlid T; Tham E; Haider Z; Joelsson J; Thorvaldsdottir B; Krstic A; Wahlin BE; Foroughi-Asl H; Karlsson C; Eloranta S; Saft L; Palma M; Kwiecinska A; Hansson L; Osterborg A; Wirta V; Rassidakis G; Sander B; Sonnevi K; Rosenquist R
Corrigendum: LEUKEMIA. 2023;37(2):504
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Dec, 10.1038/s41375-022-01802-y, 2022)
Mansouri L; Thorvaldsdottir B; Sutton L-A; Karakatsoulis G; Meggendorfer M; Parker H; Nadeu F; Brieghel C; Laidou S; Moia R; Rossi D; Catherwood M; Kotaskova J; Delgado J; Rodriguez-Vicente AE; Benito R; Rigolin GM; Bonfiglio S; Scarfo L; Mattsson M; Davis Z; Gogia A; Rani L; Baliakas P; Foroughi-Asl H; Jylha C; Skaftason A; Rapado I; Miras F; Martinez-Lopez J; de la Serna J; Rivas JMH; Thornton P; Larrayoz MJ; Calasanz MJ; Fesus V; Matrai Z; Bodor C; Smedby KE; Espinet B; Puiggros A; Gupta R; Bullinger L; Bosch F; Tazon-Vega B; Baran-Marszak F; Oscier D; Nguyen-Khac F; Zenz T; Terol MJ; Cuneo A; Hernandez-Sanchez M; Pospisilova S; Mills K; Gaidano G; Niemann CU; Campo E; Strefford JC; Ghia P; Stamatopoulos K; Rosenquist R
Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S777
Risk and mortality of testicular cancer in patients with psychiatric or neurodevelopmental disorders
Jansson AK; Soderling J; Reutfors J; Thor A; Skold C; Cohn-Cedermark G; Stahl O; Smedby KE; Pettersson A; Glimelius I
Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(2):243-261
Application of precision medicine in clinical routine in haematology-Challenges and opportunities
Wasterlid T; Cavelier L; Haferlach C; Konopleva M; Froehling S; Ostling P; Bullinger L; Fioretos T; Smedby KE
Letter: ACTA ONCOLOGICA. 2022;61(7):809-813
Cancer in young adulthood - classifying the intensity of treatment
Hedman C; Ahlgren J; Smedby KE; Hellman K; Henriksson R; Stahl O; Wettergren L; Lampic C
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:169-170
RISK OF HAEMATOLOGICAL MALIGNANCY IN PATIENTS WITH PSORIATIC ARTHRITIS, OVERALL AND IN RELATION TO TNF INHIBITORS - A NORDIC COHORT STUDY
Cordtz R; Askling J; Delcoigne B; Smedby KE; Baecklund E; Ballegaard C; Isomaki P; Aaltonen K; Gudbjornsson B; Love T; Provan SA; Michelsen B; Sexton J; Dreyer L; Hellgren K
Letter: ACTA ONCOLOGICA. 2022;61(5):597-601
Overall survival and registration of cutaneous T-cell lymphoma patients in Sweden: a multi-center cohort and validation study
Nenonen J; Winther AH; Leijonhufvud E; Belfrage E; Smedby KE; Brauner H
Review: LANCET HAEMATOLOGY. 2022;9(5):e374-e384
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
Thanarajasingam G; Minasian LM; Bhatnagar V; Cavalli F; De Claro RA; Dueck AC; El-Galaly TC; Everest N; Geissler J; Gisselbrecht C; Gormley N; Gribben J; Horowitz M; Ivy SP; Jacobson CA; Keating A; Kluetz PG; Kwong YL; Little RF; Matasar MJ; Mateos M-V; McCullough K; Miller RS; Mohty M; Moreau P; Morton LM; Nagai S; Nair A; Nastoupil L; Robertson K; Sidana S; Smedby KE; Sonneveld P; Tzogani K; van Leeuwen FE; Velikova G; Villa D; Wingard JR; Seymour JF; Habermann TM
Letter: HAEMATOLOGICA. 2022;107(3):740-743
Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen - a real world study on patients diagnosed in Sweden 2007-2017
Albertsson-Lindblad A; Palsdottir T; Smedby KE; Weibull CE; Glimelius I; Jerkeman M
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2022;196(2):437-440
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial
Fjorden K; Ekberg S; Kuric N; Smedby KE; Lagerlof I; Larsen TS; Jorgensen JM; de Nully Brown P; Jerkeman M
Corrigendum: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(6):1407
Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting (vol 35, pg 105, 2021)
Krakowski I; Bottai M; Habel H; Masucci G; Girnita A; Smedby KE; Eriksson H
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:81
RISK OF BREAST CANCER BEFORE AND AFTER RHEUMATOID ARTHRITIS, AND THE IMPACT OF HORMONAL FACTORS
Wadstrom H; Pettersson A; Smedby KE; Askling J
Corrigendum: CANCER CAUSES & CONTROL. 2020;31(6):607
Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study (vol 31, pg 451, 2020)
Wade NB; Chang CM; Conti D; Millstein J; Skibola C; Nieters A; Wang SS; De Sanjose S; Kane E; Spinelli JJ; Bracci P; Zhang Y; Slager S; Wang J; Hjalgrim H; Smedby KE; Brown EE; Jarrett RF; Cozen W
Editorial comment: ACTA ONCOLOGICA. 2020;59(3):247-248
Immune checkpoint inhibitors in cancer treatment and potential effect modification by age
Eriksson H; Smedby KE
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(2):307-308
Increased risk of multiple myeloma in primary Sjogren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies
Mofors J; Bjoerk A; Smedby KE; Kvarnstrom M; Forsblad-d'Elia H; Magnusson-Bucher S; Eriksson P; Mandl T; Baecklund E; Nordmark G; Wahren-Herlenius M
Review: LEUKEMIA & LYMPHOMA. 2019;60(13):3116-3131
Socioeconomic impact of Hodgkin lymphoma in adult patients: a systematic literature review
Palmarsdottir R; Ovlisen AK; Severinsen MT; Glimelius I; Smedby KE; El-Galaly T
Letter: INTERNATIONAL JOURNAL OF CANCER. 2019;145(6):1706-1707
Author's reply to: A note on competing risks in analyses of cancer-specific mortality
Benoni H; Smedby KE; Eloranta S
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2019;186(3):e24-e27
Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas.
Ellin F; Maurer MJ; Srour L; Farooq U; Jerkeman M; Connors JM; Smedby KE; Bennani NN; Ansell SM; Slack GW; Cerhan JR; Relander T; Feldman AL; Savage KJ
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):759-760
Is Longer Progression-Free Survival a Goal Worth Pursuing in Follicular Lymphoma? Reply
Lockmer S; Ostenstad B; Hagberg H; Holte H; Wahlin BE; Wader KF; Smedby KE; Brown P; Kimby E
Conference publication: BLOOD. 2018;132:4200
Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
Smedby KE; Harrysson S; Andersson P-O; Enblad G; Ekberg S; Jerkeman M; Eloranta S
Editorial comment: LANCET HAEMATOLOGY. 2018;5(11):e510-e511
Real-world evidence in safety assessment of new treatments
Smedby KE; Eloranta S
Letter: ANNALS OF ONCOLOGY. 2018;29(8):1882-1883
Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study
Wasterlid T; Biccler JL; Brown PN; Bogsted M; Enblad G; Jorgensen JM; Christensen JH; Wahlin BE; Smedby KE; El-Galaly TC; Jerkeman M
Letter: HAEMATOLOGICA. 2018;103(4):e158-e161
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy
Baliakas P; Mattsson M; Hadzidimitriou A; Minga E; Agathangelidis A; Sutton L-A; Scarfo L; Davis Z; Yan X-J; Plevova K; Sandberg Y; Vojdeman FJ; Tzenou T; Chu CC; Veronese S; Mansouri L; Smedby KE; Giudicelli V; Nguyen-Khac F; Panagiotidis P; Juliusson G; Anagnostopoulos A; Lefranc M-P; Trentin L; Catherwood M; Montillo M; Niemann CU; Langerak AW; Pospisilova S; Stavroyianni N; Chiorazzi N; Oscier D; Jelinek DF; Shanafelt T; Darzentas N; Belessi C; Davi F; Ghia P; Rosenquist R; Stamatopoulos K
Published conference paper: JOURNAL OF INTERNAL MEDICINE. 2017;282(5):360-370
The aetiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections.
Smedby KE; Ponzoni M
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2017;282(5):358-359
Introduction to the symposium 'Targeted therapy in B-cell malignancies'
Smedby KE; Rosenquist R
Letter: HAEMATOLOGICA. 2016;101(9):e369-e373
ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres
Navrkalova V; Young E; Baliakas P; Radova L; Sutton L-A; Plevova K; Mansouri L; Ljungstrom V; Ntoufa S; Davis Z; Juliusson G; Smedby KE; Belessi C; Panagiotidis P; Touloumenidou T; Davi F; Langerak AW; Ghia P; Strefford JC; Oscier D; Mayer J; Stamatopoulos K; Pospisilova S; Rosenquist R; Trbusek M
Letter: HAEMATOLOGICA. 2016;101(2):e63-e65
UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?
Bhoi S; Baliakas P; Cortese D; Mattsson M; Engvall M; Smedby KE; Juliusson G; Sutton L-A; Mansouri L
Corrigendum: JOURNAL OF CANCER SURVIVORSHIP. 2015;9(4):610-611
Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time-a population-based comparative study (vol 9, pg 599, 2015)
Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
Letter: LEUKEMIA. 2015;29(3):748-751
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk
Sava GP; Speedy HE; Di Bernardo MC; Dyer MJS; Holroyd A; Sunter NJ; Marr H; Mansouri L; Deaglios S; Karabon L; Frydecka I; Jamroziak K; Woszczyk D; Juliusson G; Smedby KE; Jayne S; Majid A; Wang Y; Dearden C; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Catovsky D; Allan JM; Houlston RS
Editorial comment: ACTA ONCOLOGICA. 2014;53(6):721-723
Cancer survivorship and work loss--what are the risks and determinants?
Smedby KE
Letter: LEUKEMIA. 2014;28(3):710-713
On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort
Cortese D; Sutton L-A; Cahill N; Smedby KE; Geisler C; Gunnarsson R; Juliusson G; Mansouri L; Rosenquist R
Letter: LEUKEMIA. 2014;28(3):694-696
Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia
Mansouri L; Sutton L-A; Ljungstrom V; Sorqvist EF; Gunnarsson R; Smedby KE; Juliusson G; Stamatopoulos K; Nilsson M; Rosenquist R
Review: SEMINARS IN CANCER BIOLOGY. 2014;24:61-70
Lymphoma development in patients with autoimmune and inflammatory disorders - What are the driving forces?
Baecklund E; Smedby KE; Sutton L-A; Askling J; Rosenquist R
Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:83
Comparison of lymphomas in primary and secondary Sjogren's syndrome
Vasaitis L; Nordmark G; Askling J; Ekstrom-Smedby K; Backlin C; Sundstrom C; Theander E; Baecklund E
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2013;162(6):858-862
X chromosome-wide association study of follicular lymphoma.
Conde L; Foo J-N; Riby J; Liu J; Darabi H; Hjalgrim H; Bracci PM; Smedby KE; Skibola CF
Review: ANNALS OF ONCOLOGY. 2013;24(9):2245-2255
Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph)
Kamper-Jorgensen M; Rostgaard K; Glaser SL; Zahm SH; Cozen W; Smedby KE; Sanjose S; Chang ET; Zheng T; La Vecchia C; Serraino D; Monnereau A; Kane EV; Miligi L; Vineis P; Spinelli JJ; McLaughlin JR; Pahwa P; Dosman JA; Vornanen M; Foretova L; Maynadie M; Staines A; Becker N; Nieters A; Brennan P; Boffetta P; Cocco P; Hjalgrim H
Letter: LEUKEMIA. 2013;27(2):512-514
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia
Mansouri L; Cahill N; Gunnarsson R; Smedby KE; Tjonnfjord E; Hjalgrim H; Juliusson G; Geisler C; Rosenquist R
Conference publication: HAEMATOLOGICA. 2012;97:50
450K DNA METHYLATION ARRAY ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA REVEALS GLOBAL METHYLATION TO BE RELATIVELY STABLE OVER TIME AND SIMILAR IN CLL CELLS DERIVED FROM DIFFERENT ANATOMICAL COMPARTMENTS
Cahill N; Bergh AC; Goransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Ekstrom-Smedby K; Sundstrom C; Juliusson G; Rosen A; Rosenquist R
Review: SEMINARS IN CANCER BIOLOGY. 2011;21(5):293-298
Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.
Smedby KE; Hjalgrim H
Review: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2010;172(6):621-630
Birth Order and Risk of Non-Hodgkin Lymphoma-True Association or Bias?
Grulich AE; Vajdic CM; Falster MO; Kane E; Smedby KE; Bracci PM; de Sanjose S; Becker N; Turner J; Martinez-Maza O; Melbye M; Engels EA; Vineis P; Costantini AS; Holly EA; Spinelli JJ; La Vecchia C; Zheng T; Chiu BCH; Franceschi S; Cocco P; Maynadie M; Foretova L; Staines A; Brennan P; Davis S; Severson RK; Cerhan JR; Breen EC; Birmann B; Cozen W
Letter: LEUKEMIA. 2010;24(1):211-215
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients
Gunnarsson R; Isaksson A; Mansouri M; Goransson H; Jansson M; Cahill N; Rasmussen M; Staaf J; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Juliusson G; Rosenquist R
Meeting abstract: BLOOD. 2009;114(22):516
LPL Is the Strongest Prognostic Factor in a Comparative Study of RNA-Based Markers in Chronic Lymphocytic Leukemia
Kaderi MA; Kanduri M; Mansouri M; Buhl AM; Sevov M; Cahill N; Gunnarsson R; Jansson M; Smedby KE; Hjalgrim H; Juliusson G; Jurlander J; Rosenquist R
Conference publication: BLOOD. 2009;114(22):114-115
Risk of EBV-Positive Hodgkin Lymphoma Varies Over 30-Fold by HLA Class I Genotype and History of Infectious Mononucleosis
Jarrett R; Johnson PCD; Rostgaard K; Lake A; Shield L; Little A-M; Ekstrom-Smedby K; Adami HO; Glimelius B; Dutoit SH; Kane E; Taylor GM; McConnachie A; Ryder LP; Sundstrom C; Andersen PS; Chang ET; Alexander F; Melbye M; Hjalgrim H
Review: JOURNAL OF INTERNAL MEDICINE. 2008;264(6):514-527
Autoimmune and inflammatory disorders and risk of malignant lymphomas - an update
Smedby KE; Askling J; Mariette X; Baecklund E
Conference publication: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2007;37:58
Allergy and Hodgkin lymphorna -: an epidemiological investigation
Hjalgrim H; Ekstrom-Smedby K; Rostgaard K
Review: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006;15(11):2069-2077
Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics
Ekstrom Smedby K; Baecklund E; Askling J
Review: ACTA ONCOLOGICA. 2006;45(3):258-271
Epidemiology and etiology of non-Hodgkin lymphoma -: a review
Ekström-Smedby K
Thesis / dissertation: 2005
Ultraviolet light, autoimmune disorders and the etiology of malignant lymphomas
Ekström Smedby, Karin
Show more

Grants

Uptake and outcome of new treatments for lymphoma at a national level
Swedish Cancer Society
1 January 2024 - 31 December 2026

Employments

Professor/Assistant Senior Physician, Department of Medicine, Karolinska Institutet, 2021-

Degrees and Education

Docent, Karolinska Institutet, 2010
Doctor Of Philosophy, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 2005

Supervisor

Erik Boberg, 2023
Linn Deleskog Spångberg, 2022
Johanna Borg Bruchfeld, Sex-related differences in incidence and outcomes among patients with lymphoma: epidemiological and biological perspectives, https://ki.se/en/people/johanna-borg-bruchfeld, 2021
Joshua Entrop, Childbearing after modern-day intensive immunochemotherapy in young Hodgkin and non-Hodgkin lymphoma survivors, https://ki.se/en/people/joshua-entrop, 2020
Joel Joelsson, 2019
Stina Fuentes, Adverse effects and quality of life after radiotherapy and surgery for rectal cancer - a randomized controlled trial enriched with register data, 2016

About me

Teaching

Selected publications

Articles

All other publications

Grants

Employments

Degrees and Education

Supervisor

News from KI

Events from KI